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ABSTRACT
Failure of atherosclerotic plaques can lead to potentially life threatening
clinical events such as myocardial infarction (MI), stroke, or transient ischemic
attack (TIA). The most frequently described plaque failure mechanism is tensile
rupture of the fibrous cap; however, often during angioplasty another plaque failure
mechanism occurs in which the atherosclerotic plaque separates from the internal
elastic lamina (IEL). This study aims assess the material strength of atherosclerotic
lesions using mechanical concepts.
To assess likelihood of plaque dissection at the vessel wall, adhesion
strength was assessed in both mouse and human specimens using plaque
delamination experiments. Measuring plaque adhesion in transgenic mouse
models can be useful in understanding the contributions to plaque adhesion from
specific proteins. Comparing these results to similar delamination experiments in
human plaques aids in understanding the similarities between mechanical
properties of plaques in the two species.
To further understand adhesive failure at the plaque-IEL interface, the
contributions of adhesive proteins to the mechanical strength of the plaque-IEL
interface were investigated. The results from a novel semi-quantitative plaque
immunoblotting technique and measurements of adhesive strength of thin protein
films combine to provide an estimate of the adhesive strength of relevant matrix
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proteins at approximate ex vivo concentrations. The adhesion strength in thin
protein films is much lower than that determined from in situ plaque adhesion
experiments and suggests that bridging fibers, rather than adhesive proteins, are
likely to be responsible for the adhesive strength of the plaque-IEL interface.
In addition to plaque adhesion strength, plaque stability was also assessed
by investigating the resistance to tensile rupture of the fibrous caps in human
carotid endarterectomy specimens. Mechanical strength of fibrous caps was
assessed during failure by calculating crack tip opening displacement (CTOD) and
stress in the uncracked segment (UCS) in miniature single edge notched tensile
(MSENT) specimens. The results show that fibrous caps with greater collagen
content exhibit more brittle behavior and fail at a higher stress and a smaller CTOD
than those with a lower collagen content, which exhibit a more ductile response.
Knowledge of the collagen content in the fibrous cap prior to surgical intervention
could predict the mechanical response of the fibrous cap and aid in determining
the optimal treatment plan.
Fracture toughness was used to assess plaque resistance to two different
failure mechanisms: 1) plaque delamination at the plaque-IEL interface and 2)
tensile rupture of the fibrous cap. Collagen is a vital structural component of
atherosclerotic plaques and is crucial in determining the mechanical response of
fibrous caps. Fibrillar forms of collagen, such as collagen I, or other fibrillar
proteins, such as fibrillin-1, are likely responsible for the mechanical strength of the
plaque-IEL interface.
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CHAPTER 1
INTRODUCTION
Atherosclerotic plaque rupture can lead to myocardial infarction (MI) or
ischemic stroke, which are two of the leading causes of death in the United States
[1]. There were approximately 7.6 million MIs in 2014 in the US alone. It is
estimated that by 2030 there will be 3.4 million strokes in American adults, a 20%
increase in prevalence since 2012. The total cost of cardiovascular disease and
stroke in the United States in 2010 is estimated to be over $315 billion [2].
1.1 Structure and composition of the arterial wall
There are two main types of arteries: elastic arteries and muscular arteries.
Elastic arteries, such as the aorta, typically consist of three concentric tissue
layers: the intima, the media, and the adventitia. Figure 1, used with permission
from reference [3], shows a diagram of a typical elastic artery. The intima is the
innermost layer and primarily consists of a single layer of endothelial cells which
rest on a basement membrane and subendothelial layer. In diseased
atherosclerotic arteries, the intima thickens in the subendothelial layer with
inflammatory cells, lipids, calcium deposits, and collagen fibers. This thickening
can be so severe that in these cases the intima actually bears a significant portion
of the load in these regions [3]. The middle layer of the artery, the media, consists
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of a network of collagen fibers, elastin, and smooth muscle cells (SMCs). A series
of elastic lamellae separate the media into several layers of a fiber reinforced
material. The innermost elastic layer, the internal elastic lamina, separates the
media from the intima, and the outermost, the external elastic lamina, separates
the media from the adventitia. Collagen and elastin are the major load bearing
extracellular matrix (ECM) proteins present in arteries [3]–[5]. Elastin, a primary
component of the media, allows for the reversible stretching of the artery, which
repeatedly occurs in elastic arteries due to the pulsatile blood flow originating from
the heart. Elastic fibers appear wavy and unengaged at low pressures; however,
they straighten at physiological blood pressures and are likely the primary load
bearing elements [5], [6]. The adventitia is the outermost layer of the artery and is
primarily composed of thick bundles of collagen, fibroblasts (fibrocytes),
macrophages, and resident stem cells. Collagen, unlike elastin, primarily engages
at higher than normal physiological pressures to prevent rupture of the artery [3],
[5] - [7].

Figure 1.1 A typical elastic artery. The intima is designated by ‘I’, the media ‘M’,
and the adventitia, ‘A’. This figure was reused with permission from [3].
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Though collagen and elastin provide most of the load bearing support,
glycoproteins, such as fibrillin-1, fibronectin, or other glycoproteins with adhesive
properties, may be involved in physically binding the layers of the artery together.
Fibrillin-1 is the major component of individual microfibrils which associate with
mature elastic fibers [8]; however, they are found in the absence of elastin in some
locations, such as the ciliary zonula of the eye and superficial regions of the skin
[9]. Microfibrils, even without the presence of elastin, have been shown to
contribute to the structural integrity of the tissue [10]. They have been found linking
the abluminal surface of endothelial cells to the internal elastic lamina in neonatal
rat aorta [11]. Therefore, microfibrils may be important structural elements in
vascular tissue, even in the absence of elastin. There is also evidence to support
adhesive proteins, such as fibronectin, as important structural proteins in vascular
tissue. Fibronectin has a multidomain structure which enables binding to cell
surfaces as well as to other ECM molecules, such as collagen, microfibrils, and
proteoglycans [11]–[13]. Therefore, fibronectin may be a structural link between
cells and ECM components. Other, unidentified adhesive and fibrillar proteins may
also contribute to the structural integrity of healthy and diseased vasculature.
There

are

many

adhesive

glycoproteins,

e.g.

laminin,

osteopontin,

thrombospondin, in tissue. In fact, an entire class of proteins, matricellular proteins,
may be important to consider. While matricellular proteins are not primary
structural proteins like collagen or elastin, they can modulate cell-matrix
interactions and therefore may affect adhesion strength [14].
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1.2 Atherosclerosis
Development and progression of atherosclerotic lesions
The development of atherosclerosis is a decades-long process that begins
with thickening of the intima. This thickening, known at adaptive intimal thickening,
primarily consists of SMCs, proteoglycans, and elastin, and is likely an adaptation
to maintain homeostatic flow and shear stress [15]. In 1995 Williams and Tabas
described the “response-to-retention” hypothesis, still a valid hypothesis of
atherogenesis today [16]. The first step of atherogenesis, according to the
response-to-retention hypothesis, is sequestration of lipoproteins in the thickened
intima by binding to proteoglycans in the ECM. Lipoproteins bound to
proteoglycans are more likely to be oxidized, which leads to uptake by macrophage
cells.

The process is advanced by macrophages secreting additional

proteoglycans that further increase lipid retention in the vascular wall [17].
Macrophages ingest and store lipoproteins, which are rich in cholesterol, resulting
in the formation of foam cells [18], [19]. Foam cells sometimes ingest too much
cholesterol to store as cholesterol esters, resulting in high levels of free cholesterol.
High levels of free cholesterol trigger apoptosis in cells, resulting in necrosis of the
foam cells [19]. When the resulting necrotic core is covered by a thin fibrous cap,
the plaque configuration is particularly vulnerable to plaque rupture, potentially
leading to myocardial infarction and stroke [20]–[22].
There are several key processes involved in the development of
atherosclerosis, such as lipoprotein retention, macrophage infiltration, apoptosis,
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and necrosis of the lipid core. The order and interaction between these processes
is not well understood. Repeated cycles of atherogenic events at different time
points during plaque development likely contribute to the heterogeneous nature
and unpredictable progression of atherosclerotic plaques. One potential sequence
of atherosclerotic lesion development is shown in Figure 1.2.

Figure 1.2 The progression of atherosclerosis. The histological images were
stained with Movat’s pentachrome. This image is reused with permission from [22].
There is some disagreement regarding the initiation of atherosclerotic
lesions. While intimal xanthoma and adaptive intimal thickening are both
considered non-atherosclerotic due to their limited clinical impact, the sequence
and interaction between these two states is not well known. Some studies argue
that intimal xanthomas are a separate initiation pathway to atherosclerotic lesions
[20], while other studies hypothesize that xanthomas develop at sites of adaptive
intimal thickening [22] (and as shown in Figure 1.2). Atherosclerotic lesions
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progress by accumulating lipids and macrophages within the intima, developing a
distinct fibrous cap composed of SMCs and collagen, and accumulating calcium
deposits within the lesion [22]. Many of these processes are concurrent and the
exact processes are difficult to sequence; however, various stages can be
classified using the morphological characteristics described in the next section.
Classification of atherosclerotic lesions
There are several methods of classification of atherosclerotic lesions;
however, the most widely referenced classification scheme linking plaque
morphology to clinical disease state was first introduced by Virmani, et al. in 2000
[20]. Based on this classification, there are seven categories of lesions.
Virmani, et al. proposed two potential initiation mechanisms in
atherosclerosis: intimal thickening and intimal xanthoma. An intimal xanthoma is
characterized by an accumulation of macrophages in the intima of the vessel,
whereas intimal thickening primarily consists of SMCs, proteoglycans, and elastin.
The intermediate stage is termed pathologic intimal thickening (PIT) and is
characterized by lipid presence in the lesion without necrosis. The lipid pools are
covered with a thin layer of proteoglycans and SMCs, with small numbers of
macrophages [18], [20]. The fibrous cap atheroma contains a true necrotic core
along with a distinct fibrous cap which consists of SMCs, collagen, proteoglycans,
and typically higher levels of macrophages and lymphocytes than those in PIT
lesions. The thin cap fibroatheroma (TCFA) is given a special distinction because
of its increased likelihood of plaque rupture. The presence of significant amounts
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of calcification within the lesion leads to two additional morphological
classifications. The first is calcified nodules, which are dense nodules of calcium
that disrupt the fibrous cap and are associated with thrombi. Fibrocalcific plaques,
on the other hand, are characterized by a heavily calcified plaque with a relatively
small necrotic core and an intact fibrous cap without any thrombus present [20].
Material failure of atherosclerotic lesions
As the atherosclerotic disease state progresses, the likelihood increases of
plaque failure resulting in a clinical event, such as myocardial infarction or stroke.
The most frequent and well described mechanism of plaque failure is plaque
rupture, during which a tear in the fibrous cap exposes the highly thrombogenic
necrotic core material. This mechanism generally occurs in lesions characterized
as a thin-cap fibroatheroma (TCFA) and is responsible for about 60% of all cases
involving thrombotic sudden coronary death. A second mechanism is plaque
erosion, which typically occurs in intimal thickening or fibroatheromas with little to
no necrotic core. However, the exact mechanism underlying plaque erosion is
unknown [20]–[23].
The size of the necrotic core is thought to play an important role in the risk
associated with TCFAs. Necrotic core material is lacking sufficient collagen to
provide mechanical support to the vessel which can lead to a greater stress applied
to the fibrous cap. Additionally, the necrotic core may erode the thin fibrous cap,
increasing the stress even further.

Ultimately, higher stresses in a material

increase the likelihood of material failure [21]–[23].
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Oftentimes, the thrombosis resulting from plaque rupture or plaque erosion
does not result in vessel occlusion and remains clinically silent. However, the
healing of the rupture or erosion sites promotes further occlusion of the vessel,
and subsequent ruptures or erosions frequently occur. Healed rupture sites are
generally characterized by a disrupted fibrous cap filled in with proteoglycans or
collagen III. There also may be multi-layering of necrotic core and lipid. Healed
erosion sites, on the other hand, typically do not have a necrotic core or a disrupted
fibrous cap. Instead, multi-layering of collagen and SMCs with proteoglycans is
evident [22], [23].
1.3 Current clinical interventions
The two most common interventional treatments for atherosclerotic carotid
artery stenosis are carotid artery stenting (CAS) and carotid endarterectomy
(CEA). CEA is an invasive surgical procedure in which the plaque and the
underlying media are dissected from the carotid artery and a vascular patch is
placed over the remaining adventitia. Carotid endarterectomy (CEA) is generally
considered the standard treatment for carotid artery stenosis, but recently carotid
artery stenting (CAS) has been suggested as an alternative, less invasive,
technique.
In CAS, a catheter is inserted into the carotid artery and a small balloon is
inflated at the lesion site. The goal is to flatten the plaque and to increase the lumen
area; however, in some cases this results in plaque dissection at the plaque
shoulder. The resulting damage is commonly treated with the implantation of a
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stent over the dissected tissue to hold the intimal and medial surfaces together to
recreate a smooth lumen [24]–[26]. CAS has been shown to result in more strokes
during the periprocedural period than CEA [27]–[29].
Estimation of the plaque mechanical properties could help assess the
optimal treatment for carotid artery stenosis. The increased risk of stroke during
the periprocedural period following CAS may be reduced if the material properties
of the plaque are considered prior to selecting a treatment. The timing of the
procedure can be optimized if we can predict which plaques are more prone to
rupture.
1.4 Fracture mechanics and biological tissues
The goal of this study is to use the principles of fracture mechanics and
material failure to gain an understanding of the failure of atherosclerotic lesions.
Assessing the adhesion strength between atherosclerotic plaques and the
underlying arterial wall may provide insight into the mechanism of plaque
dissection or delamination that sometimes occurs during balloon angioplasty.
Additionally, measuring the fracture toughness through the fibrous cap will
characterize its ability to resist a tear and ultimately to avoid rupture.
Fracture mechanics can be used to characterize the cohesive behavior of
materials, such as the tissue within the fibrous cap, as well as the properties of the
interface between two adhesive materials, such as the plaque-internal elastic
lamina (IEL) interface. Fracture toughness can be described by several metrics.
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Two that will be used in this study are energy release rate and crack tip opening
displacement (CTOD).
The energy release rate is defined as the energy required to extend a crack,
per unit of crack extension, and is based on the concept that crack extension will
occur when the energy available for crack growth exceeds the resistance of the
material [30]–[33]. Though not used previously to characterize fracture toughness
in vascular tissue, CTOD was first proposed by Wells at the British Welding
Institute to characterize failure under elastic-plastic yielding conditions [14]. Wells
observed that plastic deformation resulted in blunting at the crack tip, and that the
extent of crack-tip blunting increased in proportion to the toughness of the material.
Later, Dawes showed that CTOD is linearly related to the J-integral in elasticplastic conditions and that both are valid fracture parameters [15].
1.5 Previous Studies
Fracture mechanics has been used to characterize biological tissues in the
past. Several groups have previously used energy release rate to characterize
fracture toughness within biological tissues [30], [34], [35]. Wang et al. developed
a protocol to measure the plaque adhesion strength in mice and to determine the
effects of specific proteins on plaque adhesion using transgenic mice [36], [37].
This technique can be applied to investigate the potential contributions of
additional proteins to plaque adhesion strength.
Collagen VIII is a non-fibrillar collagen upregulated during atherosclerotic
lesion development that may impact plaque stability [38]–[40] and therefore it may
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be important to investigate the effect of collagen VIII on plaque adhesion strength.
SMC migration and proliferation are both decreased in apolipoprotein E; collagen
VIII triple knockout (ApoE-/- ;Col8-/-) mice when compared to apolipoprotein E
knockout (ApoE-/-) mice [41], [42]. SMCs adhere less strongly to collagen VIII than
to collagen I, and it is hypothesized that increased deposition of collagen VIII
masks collagen I and allows increased migration of SMCs in atherosclerotic
lesions [41]. Atherosclerotic lesions of ApoE-/-;Col8-/- mice have thinner fibrous
caps and larger necrotic cores than those of ApoE-/- Col 8+/+ mice due to decreased
migration and proliferation of SMCs [42]. Morphological characteristics including
larger necrotic cores and thinner fibrous caps are associated with increased plaque
vulnerability in humans [21], [43] and this may also be true in mice. In order to truly
assess the effects of collagen VIII on plaque stability, however, mechanical testing
of the atherosclerotic plaques must be conducted in both ApoE-/- and ApoE-/-;Col8/-

mice. Additionally, in order for the mouse plaque adhesion strength results to be

considered clinically relevant, plaque adhesion strength must also be measured in
human atherosclerotic plaques.
Measurements of plaque adhesion strength can provide some insights into
failure at the plaque-IEL or fibrous cap-lipid core interfaces, but further
investigation is necessary in order to understand the more detailed failure
mechanism. Potential failure mechanisms include breakage of fibers that bind two
tissue layers or breakage of bonds between adhesive proteins and other ECM
components. There is little known about which proteins are present at the plaque-
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IEL interface and even less known about the mechanical properties of these
proteins.
There have been several studies that have investigated the mechanical
properties of human atherosclerotic plaques using uniaxial extension tests [44]–
[49], compression tests [49]–[51], and uniaxial extension tests in both
circumferential and axial orientations [52], [53]. Most of these studies have
determined the stress-strain response under specified loading conditions;
however, few studies have measured other mechanical properties of these tissues.
Ultimate tensile strength (UTS) has been measured by a few groups in whole
plaques [46]–[48], and once in isolated fibrous caps [54]. While knowledge of the
mechanical properties of whole plaques has some utility, properties of isolated
fibrous cap specimens are more relevant to assessing plaque vulnerability to
rupture. In general, both strength and toughness need to be assessed to
understand material failure. Many engineering materials that exhibit high strength
are brittle and exhibit low fracture toughness and vice versa, though this is not
always the case, especially in complex materials such as atherosclerotic plaques.
To the author’s knowledge, there have been no reports of fracture toughness
measurements in human fibrous caps. Thus, this represents an important gap in
the literature.
1.6 Specific Aims
The overall goal of this project is to assess the mechanical failure of
atherosclerotic lesions. Mechanical characterization of these tissues may provide
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insight into the failure mechanisms and potentially determine the relevant failure
criteria. Understanding the mechanism of plaque failure is the first step in
developing a method or treatment to prevent plaque failure. Therefore, this work
may be an important step in advancing the therapeutic treatment options for
atherosclerosis.
Specific Aim 1: Determine the effects of collagen VIII on plaque adhesion strength
in mice and compare plaque adhesion strength in mice to fibrous cap adhesion
strength in human carotid endarterectomy specimens.
In order to build on previous plaque adhesion strength measurements, two
additional sets of experiments were performed. The first set of experiments
measured plaque adhesion strength in transgenic mice to assess the contributions
of collagen VIII to adhesion strength. The second set of experiments was
performed on human atherosclerotic plaques to determine whether or not the
mouse plaque adhesion strength measurements are representative of plaque
adhesion strength in humans.
Specific Aim 2: Determine the role of adhesive proteins at the plaque-IEL
interface.
The goal of specific aim 2 is to investigate separation of adhesive proteins
as a potential failure mechanism at the plaque-IEL interface using a novel
approach. Immunohistochemistry and semi-quantitative plaque immunoblotting
were used to identify and to approximately quantify several adhesive proteins at
the interface between atherosclerotic plaques and the underlying IEL in a mouse
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model of atherosclerosis. The adhesive strength between thin films of these
proteins and vascular ECM was measured using rigid double cantilever beam
(RDCB) experiments. By comparing the energy release rate in these experiments
to the energy release rate calculated from previous in situ measurements of plaque
delamination from the IEL, the role of the adhesive proteins can be determined. If
the energy release rates are greatly different between these two sets of
experiments, we can conclude that other structures, such as bridging fibers, may
play a significant role in the adhesion strength between the plaque and the IEL.
Specific Aim 3: Characterize the fracture toughness of atherosclerotic fibrous
caps in human carotid endarterectomy (CEA) specimens.
Fracture mechanics concepts were used to characterize fracture toughness
in atherosclerotic fibrous caps for the first time. In particular, crack tip opening
displacement (CTOD) and the stress in the uncracked segment (UCS) at failure
initiation were evaluated in each fibrous cap specimen. Additionally, the collagen
content was measured in each fibrous cap and compared to the mechanical testing
results.
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CHAPTER 2
ATHEROSCLEROTIC PLAQUE ADHESION STRENGTH IN
TRANSGENIC MICE AND HUMAN CAROTID ENDARTERECTOMY
SPECIMENS
2.1 Introduction
Atherosclerotic plaque failure is one of the leading causes of myocardial
infarction and stroke. There are at least two potential failure mechanisms for
atherosclerotic plaques. The first involves tensile rupture of the fibrous cap and
the second, which is prominent during angioplasty, involves plaque delamination
from the internal elastic lamina (IEL) at the plaque shoulder. During balloon
angioplasty, a catheter is inserted into the blood vessel and a small balloon is
inflated at the lesion site. The goal is to flatten the plaque and increase the lumen
area; however, in some cases this procedure results in intimal dissection at the
plaque shoulder. These localized dissections are commonly treated with the
implantation of a stent over the dissected tissue to hold the intimal and medial
surfaces together and to recreate a smooth lumen [24]–[26].
Plaque adhesion strength has previously been measured in apolipoprotein
E knockout (ApoE-/-) mice [36] and in apolipoprotein E matrix metalloproteinase12 double knock out (ApoE-/- MMP12-/-) mice [37], showing that MMP-12
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strengthens plaque adhesion, potentially by increasing the formation of gaps in the
IEL to allow for fiber bridging between the intima and the media. The methodology
developed by Wang, et al. will be used in the present work to study the effects of
collagen VIII on plaque adhesion strength by examining plaque adhesion strength
in both ApoE-/- and apolipoprotein E; collagen VIII triple knockout (ApoE -/- Col8-/-)
mice.
Collagen VIII is a non-fibrillar collagen that is upregulated during
atherosclerotic lesion development [38]–[40]. Smooth muscle cell (SMC) migration
and proliferation are both decreased in ApoE-/- Col8-/- mice when compared to
ApoE-/- mice [42], [55]. SMCs adhere less strongly to collagen VIII than to collagen
I, and it is hypothesized that increased deposition of collagen VIII masks collagen
I and allows increased migration of SMCs in atherosclerotic lesions [55].
Atherosclerotic lesions of ApoE-/- Col8-/- mice have thinner fibrous caps and larger
necrotic cores than those of ApoE-/- Col 8+/+ mice due to decreased SMC migration
and proliferation [42]. Morphological characteristics including larger necrotic cores
and thinner fibrous caps are associated with increased plaque vulnerability in
humans [21] and this may also be true in mice. In order to truly assess plaque
stability, however, mechanical testing of the atherosclerotic plaques must be
conducted in both ApoE-/- and ApoE-/- Col8-/- mice.
The current study will build on the previous work by Wang et al. [36], [37]
further by investigating adhesion strength of human fibrous caps in carotid
endarterectomy specimens. Performing the experiments on human tissue allows
for similarities between mouse and human plaque adhesion strength to be
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assessed. This analysis will also assist in determining whether or not the results
from mouse plaque adhesion strength experiments can be translated to human
atherosclerotic plaques.
2.2 Materials and Methods
2.2.1 Plaque adhesion strength in transgenic mice
All procedures involving vertebrate animals were approved by the USC
Institutional Animal Care and Use Committee. Four C57Bl6 congenic ApoE-/- mice
and seven ApoE-/- Col8-/- mice were fed a high-fat (40% of total calories) diet for
six months to develop advanced aortic atherosclerotic plaques. Mice were
euthanized by carbon dioxide asphyxiation and perfused with heparinized saline
at physiological pressure for five minutes. The adhesion strength between the
atherosclerotic plaque and the IEL was measured with cyclic peeling experiments,
based on a previously published protocol [36], [37]. In brief, the aorta was opened
longitudinally to visualize the atherosclerotic plaques. A small initial flaw was made
at the proximal end of one plaque and the free edge was gripped with forceps
which were mounted in a Bose Electroforce 3200 Test Instrument (Bose Corp.,
Framingham, MA). The Bose Test Instrument has two grips. One grip clamps the
plate which holds the mouse with exposed aorta. In the other grip, microclamps
that hold the tip of the free edge of the plaque are mounted. A stereomicroscope
equipped with a CCD camera was placed above the aorta to obtain a top-down
view of the delamination process. Figure 2.1 shows a schematic of the side view
of the experimental test setup.
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Figure 2.1 The experimental test setup. The Bose instrument prescribes a
displacement (actuator) and records the resulting force (load cell). The
microclamps are attached to the actuator and grip the tip of the plaque. A
stereomicroscope with one CCD camera is mounted overhead to take images of
the experiment.

2.2.1.1 Mechanical testing
The

Bose

Electroforce

3200

Test

Instrument

applied

controlled

displacement at a rate of 0.05 mm/s to detach the plaque in stages, and a
stereomicroscope with a monochrome Q-Imaging QICAM CCD camera acquired
images of the newly exposed area underneath the plaque at a frequency of 1 Hz.
Consecutive cycles were run with increasing total displacement until the plaque
completely separated from the vessel wall.
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2.2.1.2 Histological studies
After complete delamination, the plaques were fixed in 10% neutral buffered
formalin. The plaques were embedded in paraffin and sectioned transversely at 5
m. Masson’s trichrome staining was performed on several sections from each
plaque.
2.2.1.3 Data analysis
The energy released during the delamination, ΔE, is the area under the
load-displacement curve, shown in Figure 2.2, which is calculated from
experimental data using the trapezoidal rule for integration

∆𝐸 = ∑∞
𝑖=1

(𝑑𝑖+1 −𝑑𝑖 )∗(𝑙𝑖 +𝑙𝑖+1 )

2

(2.1)

where di and di+1 are incremental values of the displacement and li and li+1 are
incremental values of the load. The area exposed at the plaque-IEL interface
during one delamination cycle, ΔA, is measured using ImageJ by determining the
area before delamination, Ai, and the area after delamination, Af.
ΔA = Af – Ai

(2.2)

The energy release rate, G, is a measure of adhesion strength and is
calculated by dividing the energy released during delamination, ΔE, by the area
exposed during the same delamination, ΔA.

G=

𝛥𝐸
𝛥𝐴
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(2.3)

The failure load of each cycle was determined by measuring the load when
tearing initiated for each cycle, depicted in Figure 2.2.
1.2

Failure
Load

Load (g)

1.0
0.8
0.6

Energy
0.4
0.2
0
0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

Displacement (mm)

Figure 2.2 A representative image of the raw load versus displacement data. The
area under the load-displacement curve represents the energy released during
one delamination cycle. The failure load is the load at which tearing begins.
A stiffness parameter was caclulated for each delamination cycle. First, an
exponential trendline was fitted to the loading region of the load-displacement
curve. The exponetential trendline is of the form

𝐹 = 𝑎𝑒 𝑏𝛿

(2.4)

where F is the force or load, δ is the displacement, and a and b are
parameters. Taking the natural logarithm of equation 4, it becomes clear that b is
responsible for the slope of this line and a is related to the intercept.
ln(𝐹) = ln(𝑎) + 𝑏𝛿
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(2.5)

Therefore, b is defined as the stiffness parameter for each cycle. When the
natural logarithm of load is plotted versus displacement, the loading portion of the
curve becomes linear, shown in Figure 2.3. The lines with a greater slope

Load (g)

correspond to the cycles with a stiffer response.
45
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3

ln (Load)
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-2
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Figure 2.3 A set of representative load-displacement curves from three different
plaques (loading regions in solid lines, tearing and unloading regions in dashed
lines) with varied stiffness parameters (top). The natural logarithm of the load is
plotted versus displacement for the loading region of each of these curves
(bottom). The lines with steeper slopes correspond to the cycles with higher
stiffness. Stiffness parameters equal 3.4, 2.4, and 1.8 for the black, medium grey,
and light grey lines, respectively.
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A Shapiro-Wilk test was used to test the normality of the distributions of
results. For normally distributed data, a t-test was performed to test for differences
between the two genotypes and for non-normally distributed data, a Mann-Whitney
nonparametric test was used to compare the median values between the ApoE -/mice and the ApoE-/- Col8-/- mice. The results were considered significant if P was
less than 0.05.
2.2.2 Human fibrous cap adhesion strength
The plaque adhesion strength experiments conducted in mice, described in
section 2.2.1, were adapted to human plaque specimens. Rather than measure
the adhesion strength at the plaque-IEL interface as in the mouse studies, the
adhesion strength between the fibrous cap and the underlying plaque was
measured in human carotid endarterectomy plaque specimens.
The current study was approved by the IRB at Greenville Health System
on September 3, 2013 and all patients gave written informed consent. Seven fresh
carotid endarterectomy samples were obtained at the time of surgery from two
local hospitals (6 specimens from Greenville Health System, Greenville, SC; 1
specimen from Palmetto Health, Columbia, SC). The carotid endarterectomy
specimens were immersed in Belzer UW Cold Storage Solution (Bridge to Life Ltd.,
Columbia, SC, USA) immediately following excision from the patient and were kept
cool until testing. All testing was completed within 48 hours of surgery. The
specimens were sliced transversely into segments nominally 5 mm in width prior
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to mechanical testing. Several specimens were large enough that multiple samples
were prepared, resulting in a total of 11 fibrous cap delamination samples.
At the start of an experiment, the ring-shaped plaque sample was opened
with a longitudinal cut. At this cut edge, a scalpel was used to carefully introduce
a small initial delamination between the fibrous cap and the underlying plaque
tissue. The medial side of the tissue was glued to a glass plate with Dermabond
Advanced (Ethicon Inc., Somerville, NJ, USA), a topical skin adhesive. One of the
grips in the Bose Test Instrument was used to securely mount the glass plate,
while the opposite grip held a micro-clamp that gripped the delaminated tab of the
fibrous cap, as shown in Figure 2.4.

CCD
Camera
Free Edge of
Fibrous Cap

Load
Cell

Microclamps

Actuator

Glass Plate

Figure 2.4 Human fibrous cap delamination experimental setup. A schematic of
the sample prepared for mechanical testing is shown on the left; an actual sample
mounted in our testing device is shown on the right.
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Controlled displacement of the microclamps was used to further delaminate
the free edge of the fibrous cap. A charge-coupled device (CCD) camera
(Grasshopper GRAS-50S5M, Point Grey Research, Richmond, BC, Canada) was
placed above the tissue to capture images at a frequency of 1 Hz during the
delamination process.
2.2.2.1 Mechanical Testing
Consecutive delamination cycles at a rate of 0.05 mm/s were performed
under displacement control. The actuator of the Bose Test Instrument prescribes
a displacement for the microclamps which grip the plaque, and the resulting load
is recorded by the grips that mount the glass plate. The cyclic loadingdelamination-unloading cycles are performed until complete delamination of the
fibrous cap is achieved.
2.2.2.2 Histological Studies
After delamination, each portion of the tissue (delaminated fibrous cap,
underlying plaque and media) was fixed in 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4. The samples were embedded in paraffin and sectioned
transversely at 5 μm.
2.2.2.3 Data Analysis
The analysis of the results obtained in this section was performed identically
to the mouse plaque adhesion strength data analysis (see section 2.2.1.3).
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2.3 Results
2.3.1 Mouse plaque adhesion strength is unaffected by collagen VIII deficiency
Five plaques from ApoE-/- mice were tested in 17 peeling cycles, resulting
in an average local energy release rate of 15.4 J/m2. Twenty-two peeling cycles
were obtained from nine plaques from ApoE-/- Col8-/- mice, with an average local
energy release rate of 16.2 J/m2. Figure 2.5 shows that the local energy release
rates between ApoE-/- and ApoE-/- Col8-/- plaques have similar distributions, though
the maximum energy release rate for ApoE-/- Col8-/- mice is higher than that in
ApoE-/- mice.

Energy Release Rate, G (J/m2)
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ApoE -/-; Col8 -/Mouse Genotype

Figure 2.5 A box and whiskers plot shows that the distribution of local energy
release rate (G) values is similar in both mouse genotypes.
Figure 2.6 shows that the histograms for energy release rate distribution are
similar between mouse genotypes. The peak of each histogram is around 10 J/m2,
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and both distributions are positively skewed. A statistical summary of the
distributions is shown in Table 2.1. Based on the results of the Shapiro-Wilk test,
the distribution of plaque energy release rate values is non-normal (p < 0.01) in
both ApoE-/- and ApoE-/- Col8-/- mice. A Mann-Whitney test reveals that there is no
significant difference between the median energy release rates of the two
populations of transgenic mice (P-value = 0.82). The stiffness parameter
(calculated from equation 2.4) and failure load values for both genotypes were
normally distributed. A t-test shows that stiffness is reduced in ApoE-/- Col8-/- mice
compared to ApoE-/- mice (P < 0.05). The failure load values were not significantly
different between the two genotypes.
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Figure 2.6 Distribution of local energy release rate, G, for ApoE-/- and ApoE-/- Col8/- mice. For both genotypes, the distribution is positively skewed.
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Table 2.1 Statistical parameters for local energy release rate, stiffness parameter,
and failure load values for plaque delamination in ApoE-/- and ApoE-/- Col8-/- mice.

Energy
Stiffness
Failure Load
Release Rate
Parameter
(mN)
(J/m2)
-/ApoE-/ApoE-/-/- ApoE
-/ApoE-/ApoE
ApoE
Col8-/Col8-/Col8-/Mean
Standard
Deviation
First
Quartile
Median
Third
Quartile
Kurtosis
Skew

15.4

16.4

1.83

1.47

6.37

5.75

11.7

18.8

0.72

0.37

2.86

2.63

8.03

7.51

1.27

1.23

5.10

3.46

10.9

10.1

1.44

1.49

5.98

4.85

18.0

15.0

2.41

1.71

8.53

7.72

0.95
1.40

14.0
3.54

-1.06
0.61

0.00
0.12

0.69
0.88

-1.25
0.16

The histology performed on the delaminated tissue verifies that
delamination occurred between the atherosclerotic plaque and the IEL, rather than
within the media or between the media and the adventitia. Representative images
of plaque alone and plaque with media are shown in Figure 2.7. Histology was
performed on every delaminated specimen to confirm the plane of delamination.
Specimens which delaminated outside the plaque-IEL interface were not included
in this study.
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Figure 2.7 Trichrome staining on sections of peeled plaque specimens from
ApoE-/- mice verifies the plane of delamination. Representative histological images
showing plaque only, confirming delamination at the plane of interest, the plaqueIEL interface (left) and section for comparison showing plaque attached to media,
showing that in this case the delamination did not occur in the plane of interest
(right). Scale bar = 100 m.

2.3.3 Human atherosclerotic fibrous cap adhesion strength results
Eleven fibrous cap delamination experiments resulted in a total of 83
delamination cycles and an average energy release rate of 343 J/m2. There is high
variability in the local energy release rates both within one plaque sample and
between plaques from different patients, as shown in Figure 2.8. The histogram of
energy release rate values in Figure 2.9 shows a positively skewed distribution
with a frequency peak around 200 J/m2.
Table 2.2 summarizes the key statistical parameters in the human plaque
adhesion strength data set. The energy release rate measurements have a
standard deviation approximately equal to the mean. Local energy release rate,
failure load, and stiffness all have positively skewed distributions and exhibit
positive kurtosis.
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Figure 2.8 A box and whiskers plot for local energy release rate by patient. Patients
I, II, IV, and V each provided two fibrous cap delamination samples.
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Figure 2.9 Histogram of local energy release rates during fibrous cap peeling in
human carotid endarterectomy specimens.
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Table 2.2 Statistical parameters for local energy release rate, stiffness parameter,
and failure load values for human fibrous caps

Mean
Standard
Deviation
First Quartile
Median
Third Quartile
Kurtosis
Skew

Energy Release
Rate (J/m2)
343

Stiffness
Parameter
2.13

Failure Load
(mN)
360

338

0.90

276

123
221
386
3.9
2.0

1.66
2.00
2.38
19.6
3.48

148
262
504
1.5
1.3

Trichrome staining on delaminated fibrous caps was analyzed to confirm
that delamination occurred between the fibrous cap and the underlying plaque. A
representative image of both the fibrous cap and the underlying plaque is shown
in Figure 2.10.

Figure 2.10 A representative image of delaminated human fibrous cap (top) and
underlying plaque and media (bottom) stained with Masson’s Trichrome. Blue =
collagen. Scale bar represents 0.5 mm.
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2.4 Discussion
2.4.1 Mouse plaque adhesion strength is unaffected by collagen VIII
The adhesion strength between the atherosclerotic plaque and IEL as well
as the load at which tearing initiates are unchanged between ApoE -/- and ApoE-/Col8-/- mice. However, the plaques in ApoE-/- Col8-/- mice are less stiff than those
in ApoE-/- mice. Stiffness is a structural property that depends on both material
properties and specimen geometry, in this case the thickness and width of the
plaque. We have not isolated the influence of material properties and geometry on
the stiffness parameter measurements. However, Lopes et al. have previously
shown that plaque size and burden of atherosclerosis are similar between ApoE -/and ApoE-/- Col8-/- mice [42]. While these results suggest that material properties
may solely be responsible for the change in stiffness, further studies are needed
to confirm this. Lower plaque stiffness in the ApoE-/- Col8-/- mice is consistent with
previous observations of impaired fibrous cap formation in this genotype [42].
The local energy release rate for delamination of atherosclerotic lesions in
ApoE-/- mice after 8 months on diet has previously been reported with average
values of 19.2 J/m2 and 24.5 J/m2 [36], [37]. The current study finds an average
value for the local energy release rate of plaque delamination in ApoE -/- mice after
6 months on diet to be 15.4 J/m2. In general, our results agree with previous
studies, however it is important to note the difference in time points. While there is
a slight increase in adhesion strength with increased time on western diet (Figure
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2.11), a Mann-Whitney nonparametric test confirms that there is not a statistically

Energy Release Rate, G (J/m2)

significant difference in the energy release rate of these two populations.
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Figure 2.11 The effect of time on western diet on plaque adhesion strength in
ApoE-/- mice. Data for the adhesion strength from ApoE -/- mice on western diet for
8 months was obtained from [37]. Error bars represent standard deviation.
Previous studies have shown that there is a positive correlation between
local energy release rate and total collagen content as measured by Picrosirius
Red staining [37]. Our study shows that the energy release rate is unaffected by
the absence of type VIII collagen and suggests that other types of collagen may
be responsible for the differences in adhesion strength previously reported. We
have shown that the ApoE-/- Col8-/- plaques are less stiff than the ApoE-/- plaques,
which may be caused by the lack of type VIII collagen or by impaired migration of
SMCs and resulting matrix deposition, as previously reported.
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This study shows that the absence of type VIII collagen does not reduce
plaque adhesion strength and thus does not reduce the mechanical likelihood of
plaque failure by delamination at the plaque shoulder. However, these studies
have not ruled out the possibility that plaques in ApoE -/- Col8-/- mice may be more
susceptible to failure by tensile rupture of the fibrous cap.
2.4.2 Comparison between human and mouse results
The current study shows that energy release rate and failure load are one
to two orders of magnitude higher in human fibrous cap delamination than in
mouse aortic plaque delamination. While this finding may indicate structural
differences in tissue types between species, it is also important to note several
differences in methodology in the two sets of experiments. First, plaque adhesion
strength is measured in the longitudinal direction at the plaque-IEL interface in
mice, while it is measured in the circumferential direction between the fibrous cap
and the underlying lipid core in human tissue. Logistically, the diameter of the
mouse aorta is too small to readily test circumferential plaque adhesion strength.
Additionally, mouse plaques generally do not have distinct and thickened fibrous
caps as do human atherosclerotic plaques. Human plaques are highly
heterogeneous, and many plaques contain a very weak lipid core that can not
withstand the loads applied during experimental delamination. In these instances,
the lipid core disintegrates rather than delaminating cleanly from the IEL.
Other studies investigating delamination strength in human arteries have
found adhesion strength values ranging from 20 J/m2 to 100 J/m2 [56]–[58]. These
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studies investigated delamination within the layers of an artery rather than plaque
fibrous cap delamination, which could explain the higher results obtained in our
study.
While the human atherosclerotic plaques are much stronger than those
found in mice, the plaque adhesion strength data sets are qualitatively similar, in
terms of having positively skewed distributions of energy release rate and standard
deviations which are approximately equal to the means. While the quantitative
values of the mouse plaque adhesion strength may not be representative of human
samples, many of the qualitative behaviors observed during plaque delamination
are similar in both species.
2.5 Future Work
This study has examined plaque adhesion strength in both mouse and
human tissue; however, the microscopic mechanism for failure at this interface is
still unknown. Likely potential determinants of plaque adhesion strength are
adhesive proteins binding the two layers or bridging fibers extending between the
two layers. Thus, failure may involve either de-cohesion of protein-protein
interactions, fiber breakage, or both. Both of these failure mechanisms should be
investigated further.
In addition to plaque adhesion strength, other plaque rupture mechanisms
should be investigated to assess plaque stability, such as tensile rupture of the
fibrous cap. Both adhesive and tensile failure can potentially lead to clinical events,
such as stroke or myocardial infarction, and all measurements are valuable in
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providing mechanical properties for computational simulations of atherosclerotic
plaque behavior.
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CHAPTER 3
ADHESIVE PROTEIN CONTRIBUTIONS TO THE MECHANICAL
STRENGTH AND INTEGRITY OF THE PLAQUE-INTERNAL
ELASTIC LAMINA (IEL) INTERFACE IN A MOUSE MODEL OF
ATHEROSCLEROSIS1

1

L.A. Davis, M.A. Sutton, S.M. Lessner. To be submitted to Annals of
Biomedical Engineering.
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3.1 Introduction
Atherosclerotic plaque failure is one of the leading causes of myocardial
infarction. There are at least two potential failure mechanisms for atherosclerotic
plaques. The first involves tensile rupture of the fibrous cap and the second, which
is prominent during angioplasty, involves plaque delamination from the internal
elastic lamina (IEL) at the plaque shoulder. During balloon angioplasty, a catheter
is inserted into the blood vessel and a small balloon is inflated at the lesion. The
goal is to flatten the plaque and to increase the lumen area; however, in some
cases this results in intimal dissection at the plaque shoulder. The resulting arterial
damage is commonly treated with the implantation of a stent over the dissected
tissue to hold the intimal and medial surfaces together and to recreate a smooth
lumen [25], [26], [59].
Identifying the matrix proteins responsible for adhesion between the plaque
and the IEL may provide insight into the delamination mechanism for
atherosclerotic plaque failure at the shoulder. Wang et al. have used plaque
peeling experiments to determine the local energy release rate, G, a measure of
adhesive strength between the plaque and the IEL [36], [37]. A significant positive
correlation was found between local collagen content in the plaque and adhesion
strength between the plaque and the IEL, suggesting that collagen is an important
determinant of plaque adhesion strength [37].
Tsamis et al. have shown that during vascular remodeling of the
extracellular matrix (ECM) due to aneurysm, collagen and elastin fibers become
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radially oriented [60]. Vascular remodeling also occurs due to atherosclerotic
plaque formation and may result in a similar reorganization of fibers. If radially
oriented fibers are present at the plaque-IEL interface, they may be responsible
for the adhesion strength at this interface. Previous studies in our lab have shown
that IEL degradation increases adhesion strength between the plaque and the IEL,
raising the possibility that fiber bridges extending between the intima and media
contribute to interfacial toughness [37]. The composition of these potential bridges
is unknown, though they likely form from proteins found in the surrounding ECM.
Contributions to adhesion strength may also come from adhesive proteins that link
ECM components together. Potential failure mechanisms at the plaque-IEL
interface include a) fiber breakage, b) fiber pull out or decohesion from the
surrounding ECM, c) adhesive failure mediated by glycoproteins, or d) any
combination of the three.
In this study, we seek to characterize the ECM composition at the mouse
plaque-IEL interface and to investigate the potential contribution of specific matrix
constituents to interfacial adhesion strength. The matrix proteins selected for
investigation are collagen I, collagen IV, fibrillin-1, fibronectin, and osteopontin.
These proteins were chosen to include both adhesive glycoproteins and fibrillar
ECM proteins known to be present within atherosclerotic plaques. In addition, we
used biomechanical methods to investigate the adhesive/cohesive strength of thin
films of purified protein to determine how strongly these matrix proteins adhere to
decellularized aortic matrix.
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Based on the results in Wang et al. [37], collagen is a potential contributor
to plaque adhesion strength. Collagen I, a fibrillar collagen, is the most abundant
protein in vascular tissue. Collagen IV is a basement membrane protein that forms
structural networks or scaffolds which interact with proteoglycans [61], [62] and
cells [63], [64] and. In healthy tissue, collagen IV is found at the intimal-medial
border, and we hypothesize that collagen IV will also be present at the plaque-IEL
interface in the atherosclerotic diseased state.
Fibrillin-1 is a key component of microfibrils, which provide a scaffold for
elastic fiber formation. Though microfibrils are primarily associated with mature
elastic fibers [8], they are found in the absence of elastin in ciliary zonula of the
eye and superficial regions of the skin [9]. In the absence of elastin, microfibrils
contribute to the structural integrity of the tissue [10] and exhibit nonlinear material
behavior [65]. Microfibrils frequently interact with the basement membrane via
perlecan [66] and can adhere to cells [67]. Additionally, microfibrils have been
shown to link endothelial cells to the internal elastic lamina in developing mouse
aorta [11], [12].
Fibronectin and osteopontin may contribute to the strength of the plaqueIEL interface through adhesive interactions with other ECM components.
Fibronectin has a multidomain structure which enables binding to cell surfaces as
well as to other extracellular matrix molecules, such as collagen, and
proteoglycans [13], [68], [69]. Osteopontin is a secreted adhesive protein,
commonly expressed in inflammatory and auto-immune diseases, that binds to
cellular integrins and can mediate cell-cell and cell-ECM adhesion [70].
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Osteopontin may be an important adhesive molecule at the plaque-IEL interface
because of its ability to bind directly to fibronectin [71] and collagen [72]. Therefore,
both fibronectin and osteopontin may be structural links between ECM
components and cells at the plaque-IEL interface.
In situ blotting, or histoblotting, has been used previously to transfer protein
directly from frozen or fixed tissue sections to nitrocellulose or polyvinylidene
difluoride (PVDF) membranes and stain with histochemical or immunological
methods to detect specific proteins [73], [74]. This study builds on those techniques
by blotting fresh, unsectioned tissue on PVDF membranes along with a series of
protein standards to allow for approximate protein quantitation. More specifically,
we investigate the protein concentration at the plaque-IEL interface by blotting
fresh atherosclerotic plaques peeled from the IEL onto PVDF membranes.
Khayer Dastjerdi et al. developed an elegant technique, the rigid double
cantilever beam (RDCB) test, for measuring the fracture toughness during
cohesive failure of soft biological adhesives [75]. This RDCB technique also allows
for direct determination of the full traction-separation function. The RDCB
technique is slightly modified in this study, by adding a layer of decellularized aorta
between each beam and the protein layer. Using this modified technique, the
fracture toughness of isolated proteins can be determined for failure at the
interface between the protein layer and the matrix or within the protein layer itself.
Combining these two techniques allows for an interesting study on the
contributions of specific proteins to mechanical strength. For this study specifically,
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we have investigated the contributions of adhesive proteins to the delamination
strength, or adhesive strength, of the plaque-IEL interface. However, this
technique can be applied to a broad range of biological materials.
3.2 Materials and Methods
3.2.1 Immunohistochemistry
All procedures involving vertebrate animals were approved by the USC
Institutional Animal Care and Use Committee. Apolipoprotein E knockout (ApoE -/)
mice were put on a Western (42 kcal% fat, Harlan-Teklad, Indianapolis, IN) diet for
eight months to develop advanced atherosclerotic plaques in the descending
aorta. After eight months, two mice were sacrificed by CO2 asphyxiation and
perfused with heparinized saline for five minutes. The aorta from each mouse was
harvested and fixed in neutral-buffered formalin, embedded in paraffin, and
sectioned transversely at five μm.
Immunohistochemistry (IHC) was used to determine the presence and
distribution of collagen I, collagen IV, fibrillin-1, osteopontin, and fibronectin in
sections of the aortic wall with atherosclerotic lesions. Collagen I, collagen IV,
fibrillin-1, fibronectin and osteopontin were detected with the following antibodies,
respectively: rabbit anti-collagen I polyclonal antibody (1:20 dilution, Calbiochem,
San Diego, CA), rabbit anti-collagen IV polyclonal antibody (1:20 dilution, Abcam,
Cambridge, MA), rabbit anti-fibrillin-1 polyclonal antibody (1:20 dilution, Abcam,
Cambridge, MA), rabbit anti-fibronectin antibody (1:100 dilution, Novus Biologicals,
Littleton, CO), and rabbit anti-osteopontin antibody (1:100 dilution, Abcam,
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Cambridge, MA). Donkey anti-rabbit rhodamine red X (RRX)–labeled secondary
antibodies (Jackson Immuno Research Laboratories, Inc., West Grove, PA) were
used to detect collagen I, fibronectin, and osteopontin. For collagen IV and fibrillin1, biotin-conjugated donkey anti-rabbit IgG (Jackson Immuno Research
Laboratories, Inc., West Grove, PA) was used as a secondary antibody, followed
by RRX-labelled streptavidin (Jackson Immuno Research Laboratories, Inc., West
Grove, PA). Lastly, the tissue sections were counterstained with Hoechst 33342
(1:10,000 dilution, Thermo Fisher Scientific, Waltham, MA). A Zeiss LSM 510
confocal microscope was used to capture images at 40X and 63X magnification.
3.2.2 Semi-quantitative plaque immunoblotting
A novel plaque immunoblotting technique was used to identify and quantify
adhesive proteins present locally at the plaque-IEL interface. Five ApoE-/- mice
were sacrificed by CO2 asphyxiation and perfused with heparinized saline for five
minutes. The descending aorta was opened longitudinally to visualize the
atherosclerotic lesions. Forceps were used to make an initial flaw at one edge of
the plaque-IEL interface. The free edge of the plaque was gripped and gently
peeled from the aortic wall. A total of 23 plaques from 5 mice were used in these
experiments. The plaque was briefly blotted three times in sequence onto adjacent
areas of a PVDF membrane (the IEL interface side contacting the membrane) that
had been rinsed with methanol and transfer buffer (25 mM Tris, 192 mM glycine,
20% (v/v) methanol). A set of protein standards (rat tail collagen I, EMD Millipore
Corporation, Billerica, MA; mouse collagen IV, BD Biosciences, Bedford, MA;
partial recombinant fibrillin-1, Novus Biologicals, Littleton, CO; human plasma
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fibronectin, EMD Millipore Corporation, Billerica, MA; human recombinant
osteopontin, BioVision Inc., Milpitas, CA) at known concentrations was applied to
the membrane to allow for approximate quantitation of the protein transferred from
the plaque-IEL interface.
After the membrane had absorbed all protein, it was rinsed in Tris-buffered
saline (TBS), pH 7.4, and placed in 1% bovine serum albumin (Sigma-Aldrich, St.
Louis, MO, USA) in TBS for 1 hour. The membrane was then incubated with the
appropriate primary antibodies, see section 2.1, at modified dilutions (1:500,
1:3750, 1:1000, 1;1000, and 1:1000 for collagen I, collagen IV, fibrillin-1,
fibronectin, and osteopontin, respectively) for 1 hour, followed by biotinylated
donkey anti-rabbit IgG (1:1000 dilution, Jackson Immuno Research Laboratories
Inc., West Grove, PA) for 1 hour and IR 800 labelled streptavidin (1:1000 dilution,
LI-COR Biosciences, Lincoln, NE) for 45 minutes. The membranes were imaged
using an Odyssey CLx Imaging System (LI-COR Biosciences, Lincoln, NE) and
analyzed quantitatively using ImageJ (version 1.50c4, National Institutes of Health,
USA).
The first step in determining the ex vivo protein concentration is to create a
standard curve using samples of known protein concentrations. On some of the
plaque blots, the protein standards at the higher concentrations spread and
created a larger area of lower signal. To correct for this effect, the total signal was
calculated by measuring average pixel intensity multiplied by the area of the
protein dot. An adjusted average pixel intensity was calculated by dividing the total
pixel intensity by the area of the smallest dot on the standards. The adjusted pixel
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intensity can be viewed as the average pixel intensity, if no spreading had
occurred, and was used in all subsequent calculations. An adjusted average pixel
intensity was calculated for each spot, whether or not obvious spreading had
occurred.
The “area concentration” of each standard spot was determined by dividing
the known mass of protein added to the membrane (volume of standard x standard
concentration) by the area of the smallest standard dot (the same area used to
determine the adjusted average pixel intensity). The area concentration and the
adjusted average pixel intensity were plotted after a logarithmic transformation of
each variable, and a linear regression was performed for each set of standard
proteins. The ex vivo concentration was calculated using the linear regression to
determine the logarithmic transformed concentration, which was then converted to
true concentration. In each case, the ex vivo area concentration was calculated
based on the average pixel intensity from the first of the three adjacent plaque blot
images on the PVDF membrane.
In order to confirm proteins were only transferring from the plaque-IEL
interface, plaque blots were compared alongside tissue blots from within the media
of the aorta and stained with anti-actin smooth muscle antibody (1:500 dilution,
Thermo Fisher Scientific, Waltham, MA). Smooth muscle cells (SMCs) are present
much higher levels in the media of the artery or within the fibrous cap of the plaque,
but are relatively sparse at the plaque-IEL interface. Therefore, the signal should
be greatly reduced in the plaque blots compared to the media plots, if the technique
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only transferring protein from the interface of interest and no contamination from
other tissue surfaces is occurring.
This method is described as semi-quantitative because all protein at the
plaque-IEL interface does not necessarily transfer to the PVDF membrane in one
blot. Each plaque was blotted onto a single PVDF membrane three times, resulting
in three adjacent images. While the signal is visually similar for each plaque blot,
the calculated concentrations are generally not within 10%.

The collagen I

concentration is generally highest in the third plaque blot while the collagen IV
concentration is generally the lowest in the third blot. This suggests that protein
transfer is beginning to occur in the body of the plaque at these later blots (collagen
I is more abundant in the body of the plaque and collagen IV is less abundant
there). For this reason, only the first plaque blot is used for quantification. These
results also suggest that the majority of the protein from the plaque-IEL interface
transfers to the PVDF membrane within two blots. While true quantification cannot
be achieved, this technique is useful to investigate relative abundance among
several interfacial matrix proteins.
3.2.3 Mechanical testing of purified protein films using rigid double cantilever beam
experiments
Rigid double cantilever beam (RDCB) experiments to measure the
adhesive/cohesive strength of purified protein films were adapted from Khayer
Dastjerdi et al. [75]. To simulate dissection at the interface between arterial tissue
layers (intima-media), purified protein films were applied between two layers of
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decellularized porcine aorta prior to RDCB testing. Porcine aortas were obtained
from a local slaughterhouse (Caughman’s Meat Plant, Lexington, SC) and
decellularized in 0.1% sodium dodecyl sulfate (SDS) for 48 hours at room
temperature with gentle shaking. The tissue was placed in fresh 0.1% SDS every
24 hours.
After decellularization, the aorta was cleaned of fat and cut into a series of
segments 5 mm wide by 25 mm long. The adventitial side of each segment was
glued onto a glass beam of the same size using Dermabond (Ethicon Inc.,
Somerville, NJ, USA) (a topical skin adhesive). The glass beams were cut from
microscope slides using a carbide-tipped glass cutter and a custom framing device
to ensure uniform dimensions. At one end of the beam, a glass coverslip (0.17 mm
thick) was placed on the decellularized aorta to control the thickness and the initial
crack length of the protein film. Ten μL of protein at specified concentration (0.125,
0.25, 0.5, or 1 μg/μL) was added to the opposite end of the beam. An identical
glass beam bonded to decellularized aorta was placed on top of the first beam and
protein film to create a “sandwich” (see Figure 3.1). The beams and protein film
were incubated overnight in a humid chamber at 4C. Wooden tabs containing
2.25 mm diameter through-thickness holes were attached to each glass beam with
standard superglue.
The beams were mounted into a Bose 3200 Test Instrument (Bose Corp,
Framingham, MA) by placing 1.25 mm pins through the holes in the wooden tabs,
as shown in Figure 1. The displacement of the pins was initially increased such
that each pin was fully contacting the far edge of the hole in each hinge. Controlled
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displacement at a rate of 0.01 mm/s was applied to the sample until complete
failure occurred.

Load and displacement were recorded by the Bose 3200

software at a frequency of at least 2 Hz.

Figure 3.1 RDCB experimental setup.
3.2.3.1 Theory of Adhesion Strength Calculations
Based on the theory presented by Khayer Dastjerdi et al. [75], [76], the
exact traction-separation curve for an adhesive interface can be calculated from
RDCB data using the geometry of the beams and the load- displacement curves.

𝑡(𝛿) =

𝐿

𝑑𝐹

𝐵(𝐿−𝑎0 )
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(2𝐹 + ∆ 𝑑∆)

(3.1)

Where t is the traction, δ is the separation at the leading edge of the protein
layer, L is the length of the beams, B is the width of the beams, a 0 is the initial
crack length, F is the instantaneous force, and Δ is the opening between the two
ends of the beams. The separation, , at the crack tip is given by

𝛿=

𝐿− 𝑎0
𝐿

∆

(3.2)

The traction-separation curve was plotted until the traction reaches zero, at
which point maximum separation distance has been reached. The energy release
rate, G, was determined by measuring the area under the traction-separation curve
using the trapezoidal rule,
𝑡𝑖 +𝑡𝑖+1

𝐺 = ∑∞
𝑖=0 (

2

) ∗ (𝛿𝑖+1 − 𝛿𝑖 )

(3.3)

where ti and ti+1 are sequential traction values, and δi and δi+1 are the
corresponding sequential separation values.
To combine the results from the RDCB experiments with those collected in
Section 3.2.2, the equivalent volumetric concentration was determined for each of
the ex vivo protein concentrations measured by plaque immunoblotting. The
equivalent volumetric concentration was determined by creating a standard curve
using the volumetric concentrations of the standards rather than the area
concentrations.
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3.2.4 Scanning electron microscopy (SEM) of partially delaminated plaques
Scanning electron microscopy (SEM) was used to examine the surface of
the plaque-IEL interface. A partially delaminated plaque was prepared for SEM
imaging with standard techniques for SEM images. In brief, the samples were fixed
in 4% glutaraldehyde overnight, critical point dried, and sputter coated with gold.
Images were taken with a JEOL 6300V scanning electron microscope (JEOL USA,
Peabody, MA) at 4000X magnification.
3.2.5 Statistical Analysis
For plaque immunoblotting studies, we quantified results only from
experiments in which the protein standard curve had an R2 value greater than 0.8
and which did not require more than 10% extrapolation beyond the range of
standard values to determine the concentration of unknowns (i.e., protein area
concentrations of individual plaques). One-way ANOVA was used to compare
average ex vivo concentrations determined from plaque immunoblotting
experiments.
3.3 Results
3.3.1 Immunohistochemistry
Representative IHC results for each protein are shown in Figure 3.2. In each
case, the green signal represents tissue autofluorescence, the red signal is the
protein of interest and the blue signal corresponds to cell nuclei. Collagen I is
present consistently at the plaque-IEL interface, in the body of the plaque, and in
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the adventitia. Collagen IV is closely associated with portions of IEL. Collagen IV
is strongly associated with one section of the IEL and notably absent from an
adjacent segment of IEL. Fibrillin-1 is present at the plaque-IEL interface, though
to a lesser extent than either collagen I or collagen IV, and within the media of the
artery. There are several bright spots of signal within the body of the plaque for
fibrillin-1 staining. These spots may be microfibrils oriented perpendicular to the
plane of section. Fibronectin is present along the plaque-IEL interface, within the
media of the artery, and near the luminal plaque edge, though absent from the
plaque core. Conversely, osteopontin is most strongly associated with the plaque
core and the underlying plaque-IEL interface.

Figure 3.2 Representative Immunohistochemistry results for each matrix protein at
40X magnification (top row) and 63X magnification (bottom row). All scale bars
represent 20 μm. Arrows point to protein at the plaque-IEL interface, circles denote
protein in the body of the plaque, stars show protein within the media, and
diamonds represent protein in the adventitia.
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3.3.2 Semi-quantitative plaque immunoblotting
Representative results from the plaque immunoblotting experiments are
shown in Figure 3.3. In total, we obtained three measurements of collagen I
interfacial concentration, three measurements of collagen IV concentration, two
measurements each of fibrillin-1 and fibronectin concentration, and no
measurements for osteopontin. Osteopontin was detected at the plaque-IEL
interface using the plaque immunoblotting technique; however, the protein
standard curves were not of sufficiently high quality to quantitate the ex vivo
concentration. The standard curves were linear at low protein concentrations, but
appeared to saturate at higher concentrations in the range of the ex vivo
concentration. The quantitative results (Figure 3.4, Table 3.1) show that collagen I
and collagen IV are slightly more abundant at the plaque-IEL interface than fibrillin1 and fibronectin; however, one-way ANOVA demonstrated no significant
differences between the average concentrations of each protein. The standard
deviation in each case is approximately equal to the mean, a trend which was also
observed with the plaque adhesion strength results [36], [37]. The variation in
measured interfacial protein concentrations is consistent with the observed
variability in plaque adhesion strength measurements.
Comparison of plaque and media blots stained with anti-smooth muscle
actin show that the signal is greatly reduced in the plaque compared to the media
(Figure 3.5). These results support the notion that protein transfer is not occurring
from the media or from the fibrous cap, instead protein is only transferring from the
plaque-IEL interface where SMCs are expected to be relatively rare.
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Plaque Blots

Protein
Standards

Figure 3.3 Representative plaque immunoblotting results showing standards with
no spreading at high standard concentration (left) and standards which have
spread at the two highest standard concentrations (middle). A schematic is shown
(right). Insets show plaque blots.

Concentration (μg/mm2)

0.07
0.06
0.05
0.04
0.03
0.02
0.01
0
Collagen I
n=3

Collagen IV
Fibrillin-1
n = 3 Protein n = 2

Fibronectin
n=2

Figure 3.4 Summary of ex vivo protein concentrations at the plaque-IEL interface
determined with plaque immunoblotting. Error bars represent standard deviation.
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Table 3.1 Summary of ex vivo protein concentrations at the plaque-IEL interface
quantified by immunoblotting

Protein

Surface
Concentration
(μg/mm2)

Equivalent
Volumetric
Concentration
(μg/μL)

Standard
Curve R2

Extrapolation
from
Standard
Curve (%)

Collagen I
Collagen I
Collagen I
Average

0.020
0.003
0.049
0.024 ± 0.023

0.027
0.004
0.073
0.035 ± 0.035

0.92
0.99
0.97
-

-0.39
-

Collagen IV
Collagen IV
Collagen IV
Average

0.001
0.007
0.068
0.025 ± 0.037

0.002
0.021
0.088
0.037 ± 0.045

0.92
0.92
0.87
-

-

Fibrillin-1
Fibrillin-1
Average

0.024
0.010
0.017 ± 0.009

0.030
0.012
0.021 ± 0.013

0.98
0.97
-

-

Fibronectin
Fibronectin
Average

0.002
0.030
0.016 ± 0.020

0.003
0.057
0.030 ± 0.038

0.81
0.92
-

-4.43
-

Plaque Blots

Media Blots

Figure 3.5 A representative blot stained with anti-SMA in the plaque and in the
media (left) and schematic (right). Inset shows plaque blots.
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3.3.3 Mechanical testing using RDCB experiments
RDCB experiments were performed using collagen IV protein films at
several concentrations sandwiched between strips of decellularized porcine aorta.
A representative load-displacement curve and traction-separation curve for
collagen IV at each protein concentration is shown in Figure 3.6. The maximum
load is generally reduced with deceasing protein concentration. Similarly, the
maximum traction decreases with decreasing protein concentration while the
maximum separation is relatively unchanged. Table 3.2 summarizes the key
results from the RDCB experiments.
The results of RDCB experiments summarized in Figure 3.7 show that the
adhesion strength, or energy release rate, of thin protein films increases
exponentially with collagen IV concentration. Some of the variability in energy
release rate may be explained by the difference in porcine tissue samples from
different subjects. At the expected ex vivo equivalent concentration estimated from
the plaque immunoblotting experiments (0.037 μg/μL), the corresponding energy
release rate for collagen IV (0.62 J/m2) is approximately one order of magnitude
lower than the

published experimental measurements of mouse plaque-IEL

adhesion strength (19.3 J/m2; 24.5 J/m2) [36], [37]. This discrepancy suggests that
while collagen IV is relatively abundant at the plaque-IEL interface, it is not a key
contributor to the adhesion strength between the atherosclerotic plaque and the
IEL.
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Load (g)
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0.125 μg/μL
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1
0
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5

Displacement (mm)

12

1.000 μg/μL
0.500 μg/μL

Traction (kPa)

10

0.250 μg/μL
8

0.125 μg/μL

6
4
2
0
0

0.2

0.4

0.6

0.8

1

1.2

Separation (mm)

Figure 3.6 Representative load-displacement (top) and resulting tractionseparation curves (bottom) at each tested protein concentration.
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Table 3.2 Summary of key results from RDCB experiments.

Protein

Concentration
(μg/μL)

Average
Maximum
Traction
(kPa)

Average
Maximum
Separation
(mm)

Average
Energy
Release Rate
(J/m2)

Collagen IV
Collagen IV
Collagen IV
Collagen IV

1.000
0.500
0.250
0.125

25.1
7.28
3.58
3.75

0.82
0.83
0.51
0.86

9.98
2.58
0.66
1.22

Energy Release Rate, G (J/m^2)

20
18
16

Collagen IV

14
12

In Situ Adhesion
Strength

10
8

6
4
2
0
0

0.2

0.4

0.6

0.8

1.0

1.2

Protein Concentration (µg/µL)

Figure 3.7 RDCB results for adhesion strength of thin collagen IV films compared
to in situ adhesion strength of mouse atherosclerotic plaque (from [37]). Error bars
represent standard deviation.

3.3.4 Scanning Electron Microscopy of partially delaminated atherosclerotic
plaques
The results from SEM of partially delaminated atherosclerotic plaques show
there are several bridging fibers at the plaque-IEL interface (Figure 3.8). These
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fibers may be key structural components of the plaque-IEL interface. Radially
oriented bridging fibers between the plaque and the IEL will increase adhesion
strength and resist failure between these two layers. The number, diameter, and
orientation of these fibers may affect the overall adhesion strength at the plaqueIEL interface.

Figure 3.8 Scanning electron microscopy (SEM) of partially delaminated mouse
plaque shows bridging fibers (arrows) exist at the plaque-IEL interface. Scale bar
represents 1 m.
3.4 Discussion
The results from immunohistochemistry and plaque immunoblotting studies
show good agreement. Collagen I is clearly present at the plaque-IEL interface,
confirmed by both IHC and plaque immunoblotting results. IHC shows that
collagen IV is clearly associated with the IEL, though its distribution appears to be
somewhat heterogeneous. Heterogeneous distribution of collagen IV over the
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entire IEL surface could explain the large standard deviation in the plaque
immunoblotting results. While both fibrillin-1 and fibronectin appear to be present
at the plaque-IEL interface by IHC, the staining intensity is lower than for collagen
I or collagen IV. These results are mimicked in the plaque immunoblotting results,
where fibrillin-1 and fibronectin are slightly less abundant than collagen I and
collagen IV. The concentration of osteopontin was not quantified; however, both
IHC and plaque immunoblotting (data not shown) confirm that osteopontin is
present at the plaque-IEL interface.
Examining the results from the RDCB experiments can provide insight into
the mechanism of failure at the plaque-IEL interface by providing bounds on the
forces required to separate surfaces adhered by a thin protein film. We
hypothesize two potential sources of adhesion strength or tearing toughness at the
interface: 1) bridging fibers that extend between tissue layers and/or 2) adhesive
matrix proteins at the interface. The RDCB experiments can measure the
mechanical toughness of a thin film of adhesive protein. The results from the
RDCB experiments in this study show that collagen IV is not a likely key constituent
determining adhesive strength at the plaque-IEL interface. When extrapolating the
results of the RDCB experiments to the ex vivo protein concentration estimated by
immunoblotting, we find that collagen IV exhibits an adhesive strength
approximately one order of magnitude below previously measured in situ plaque
adhesion strengths. Even at concentrations much higher than those found ex vivo,
the adhesive strength of collagen IV is still weaker than the in situ plaque adhesion
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results. These results clearly indicate that collagen IV is not likely to be responsible
for the mechanical strength at the plaque-IEL interface.
RDCB experiments were also performed on thin films of fibronectin which
resulted in a limited number of results due to the weak mechanical strength of
these films (data not shown). The RDCB experiments measured the adhesive
properties of human plasma fibronectin rather than cellular fibronectin. Both forms
of fibronectin are encoded by a single gene and alternatively spliced to form the
different variants. Cellular fibronectin is produced by fibroblasts, endothelial cells,
and smooth muscle cells and is present as insoluble fibrils in the ECM, while
plasma fibronectin is produced only by hepatocytes and is soluble in blood plasma
and body fluids [77]–[81]. Several studies show that plasma fibronectin exhibits
adhesive properties, specifically to
glycosaminoglycans [79], [83].

cells [77], collagen [78], [82], and

Additionally, plasma fibronectin can be

incorporated into the vascular wall and form fibrils alongside cellular fibronectin
[80], [81]. While plasma fibronectin may exhibit some adhesive properties, the
RDCB results suggest that the adhesive strength is far weaker than collagen IV
and therefore unlikely to contribute to the strength of the plaque-IEL interface. The
fibrillar form of fibronectin should be further investigated as a potential contributor
to adhesion strength at the plaque-IEL interface.
Other structural proteins that match the mechanical adhesive strength
properties measured in situ must be localized to the plaque-IEL interface. Collagen
I, fibrillin-1, and fibronectin are potential candidates for the components of the
bridging fibers at the plaque-IEL interface, and this study has confirmed that these
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proteins are present at the appropriate location. However, measuring the
mechanical strength of fibers is fundamentally different than measuring the
mechanical strength of adhesive proteins. RDCB experiments are not appropriate
to directly test the mechanical strength of fibrillar proteins. First, the in vivo
orientation of fibers will significantly affect their contribution to interfacial
toughness. We did not make an effort to control fiber orientation in the thin films
used for this study. Additionally, the number and thickness of the fibers or fiber
bundles will also affect the adhesive strength of the interfacial layer. Future
examination of bridging fibers in situ at the plaque-IEL interface is necessary.
Atomic force microscopy (AFM) has been used to measure the mechanical
properties of single collagen or elastic fibers [84]–[86]; however, computational
simulations would be necessary to estimate an energy release rate from these
measurements. An alternative technique that has been used to determine the
energy release rate during fiber pull-out of individual carbon nanotubes from epoxy
composites, using a combined micromechanical tester and SEM [87], may offer
potential for determining mechanical properties of fibers at the plaque-IEL
interface.
The methodology used in this study represents a novel technique that can
be applied to determine the proteins responsible for the adhesive strength of other
biological interfaces, such as those between layers of an artery or between
cartilage and bone. The plaque immunoblotting technique can be applied to
estimate protein concentrations at other biological interfaces and surfaces. Though
RDCB of adhesive biological proteins was first proposed by Khayer Dastjerdi et
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al., the combination of this technique with plaque immunoblotting constitutes a
novel methodology that can be used to determine the adhesive strength
contribution of individual proteins or protein mixtures at biological interfaces.
The results from this study include a preliminary candidate group of
proteins, and examining additional adhesive matrix proteins is relevant future work.
Most importantly, determining the composition of the bridging fibers and measuring
their breaking strength will provide great insight into the failure mechanism at the
plaque-IEL interface. Additionally, plaque adhesion strength may result from the
synergistic interaction of several proteins forming matrix architectures that have
emergent mechanical properties. To gain additional insight into failure
mechanisms at the plaque-IEL interface, it may be necessary to evaluate
cohesive/adhesive properties of protein mixtures as well as bridging fiber pull-out
strength from native vascular ECM.
3.5 Conclusions
This study describes a novel technique that has been used to investigate
contributions of adhesive matrix proteins to the strength of the plaque-IEL
interface. We show that collagen I, collagen IV, fibrillin-1, fibronectin, and
osteopontin are all present at the plaque-IEL interface. Semi-quantitative plaque
immunoblotting shows that collagen I and collagen IV are present at slightly higher
concentrations than fibrillin-1 and fibronectin at the plaque-IEL interface, though
these differences do no reach statistical significance. RDCB experiments show
that collagen IV is unlikely to be responsible for the adhesive strength of the
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plaque-IEL interface. SEM images of a partially delaminated plaque show bridging
fibers exist at the plaque-IEL interface. These fibers, potentially composted of
collagen I, fibrillin-1 or fibronectin, are likely responsible for the adhesion strength
at the plaque-IEL interface.
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CHAPTER 4
CHARACTERIZATION OF FRACTURE BEHAVIOR OF HUMAN
ATHEROSCLEROTIC FIBROUS CAPS USING A MINIATURE
SINGLE EDGE NOTCHED TENSILE TEST2

2

L.A. Davis, S.E. Stewart, C.G. Carsten, B.A. Snyder, M.A. Sutton, S.M.
Lessner. Submitted to Acta Biomaterialia 2/13/2016.
63

4.1 Introduction
Atherosclerotic plaque rupture can lead to myocardial infarction or ischemic
stroke, two of the leading causes of death in the United States [1]. It is estimated
that by 2030 there will be 3.4 million strokes in American adults, a 20% increase
in prevalence since 2012 [2]. Atherosclerotic plaque rupture in the carotid artery
can lead to stroke or transient ischemic attack (TIA), which affect approximately
795,000 and 5 million people each year, respectively. Strokes are one of the top
causes of long-term disability, while also accounting for one in every 19 deaths in
the US [2].
Ischemic stroke can be induced by multiple mechanisms. One wellestablished cause is plaque rupture, during which a tear in the fibrous cap of an
atherosclerotic plaque exposes the highly thrombogenic necrotic core material. In
some cases, the resulting thrombosis causes vessel occlusion, during which the
patient will experience an ischemic stroke or TIA. Plaque rupture in the carotid
artery accounts for approximately 15% of all ischemic strokes [88]. This
mechanism generally occurs in lesions called a thin-cap fibroatheroma (TCFA),
characterized by a thin fibrous cap covering a large necrotic core [20]–[23]. Though
these morphological characteristics provide a good framework for identifying
vulnerable plaques, the true test of plaque vulnerability is whether or not the
mechanical strength of the tissue can withstand the physiological loading
conditions to which it is subjected. When loads experienced in vivo exceed the
mechanical strength of the fibrous cap, the tissue will fail, often resulting in
thrombus formation that may lead to ischemic stroke. The extent of damage from
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plaque rupture varies. The thrombosis from plaque rupture may remain clinically
silent if the thrombus does not completely occlude the vessel. However, healing
of the rupture sites within the fibrous cap promotes further occlusion of the vessel,
and frequently subsequent ruptures or erosions of the fibrous cap occur [22], [23].
These subsequent ruptures or erosions may result in a clinical event. Therefore,
identifying which fibrous caps are more likely to tear is a good predictor of which
plaques are more likely to result in a clinical event.
In order to predict likelihood of plaque rupture, the first step is to identify the
best metric to assess fracture toughness of the fibrous cap. While there is some
information in the literature regarding quantitative measures of fibrous cap failure,
such as ultimate tensile strength, the detailed failure mechanism of fibrous caps is
not well understood. It is important to understand how the tissue fails in order to
select the best method to assess the failure of these tissues. Examining the
fracture behavior of the tissue will provide more insight into plaque rupture than
previous studies.
With regard to quantitative metrics, several groups have previously used
energy release rate to characterize fracture toughness in soft biological tissues,
both in an adhesive layer [36], [37], [89], and within a biological tissue [30], [34],
[35]. Though not used previously to characterize fracture toughness in vascular
tissue, crack tip opening displacement (CTOD) was first proposed by Wells at the
British Welding Institute to characterize failure in elastic-plastic yielding conditions
[90]. Wells observed that plastic deformation resulted in blunting at the crack tip,
and that the extent of crack-tip blunting increased in proportion to the toughness
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of the material. Later, Dawes showed that CTOD is linearly related to the J-integral
in elastic-plastic conditions and that both are valid fracture parameters [91].
Since the fracture toughness of fibrous caps has not been studied, this
study aims to quantitatively characterize the fracture behavior of fibrous caps using
both the CTOD metric and the stress in the un-cracked segment (UCS) to assess
fracture toughness. To the authors’ knowledge this is the first application of CTOD
in vascular tissue.
4.2 Materials and methods
4.2.1 Sample preparation and dissection
The current study was approved by the IRB at Greenville Health System on
September 3, 2013 and all patients gave written informed consent. In order to be
considered for this study, patients must have greater than 50% stenosis in the
carotid artery and a prior stroke or TIA, or greater than 70% carotid artery stenosis.
Human carotid endarterectomy specimens were obtained from 8 patients at the
time of surgery at Greenville Memorial Hospital (patient demographics in Table
4.1). Two plaque specimens generated multiple samples from the same patients
(Samples III and IV; Samples VII and VIII). The excised specimens were
immediately immersed in Belzer UW Cold Storage Solution (Bridge to Life Ltd.,
Columbia, SC, USA) and were kept cool until testing. All mechanical testing was
completed within 48 hours of tissue harvest. The intact specimen, shown in Figure
4.1 (left), ranges from approximately two to five cm in length. The specimen is
nominally centered in the carotid artery bifurcation and usually contains portions

66

of the common carotid artery (CCA), the internal carotid artery (ICA), and the
external carotid artery (ECA). The intact specimen was sliced into a series of
transverse slices nominally 5-mm thick (Figure 4.1, right) using a custom slicing
device.
Table 4.1 Patient demographics
Sample
ID

Gender

Age

Region of Sample Used for Mechanical
Testing

I
II
III
IV
V
VI
VII
VIII
IX
X

M
F
M
M
M
M
M
M
F
F

46
89
84
84
60
74
86
86
74
56

Carotid Bulb
Common Carotid Artery
Carotid Bulb
Carotid Bulb
Carotid Bulb
Carotid Bulb
Internal Carotid Artery
Internal Carotid Artery
Internal Carotid Artery
Carotid Bulb

Figure 4.1 Typical examples of specimens obtained from carotid endarterectomy.
An intact specimen immediately following harvest is shown on the left, with the
common carotid artery at the bottom. The specimens are sliced into a series of 5
mm rings, as shown on the right.
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4.2.2 Mechanical testing of isolated fibrous cap
The fibrous cap was isolated for mechanical testing by dissection from the
remaining plaque. All samples were subjected to tensile loading in the
circumferential direction, corresponding to the direction of maximum wall stress
(hoop stress). Two types of mechanical tests were performed. First, uniaxial tensile
tests on the fibrous cap were performed to determine the stress-strain response of
the fibrous cap. Then, the fracture behavior within the fibrous cap was examined.
Immediately following the uniaxial tensile tests, a scalpel was used to introduce an
initial flaw on one edge in the longitudinal direction, approximately at the midpoint
between the two grips. The flaw orientation is nominally perpendicular to the
longitudinal edge, with the loading applied parallel to the longitudinal edge (i.e.,
along the in-vivo circumferential direction).
4.2.2.1 Experimental setup
The isolated fibrous cap was mounted into a set of metal grips, with 100 grit
sandpaper on the inner surface to minimize slippage. The grips were connected to
a Bose 3200 Test Instrument (Bose Corp., Framingham, MA, USA). One grip was
stationary and connected to a load cell, while the other grip was connected to an
actuator. All experiments were performed in displacement control.

Both the

uniaxial load and displacement were recorded at a rate of 2 Hz or higher during
the experiment. Due to the unique geometry of each plaque specimen, in some
cases the length of the isolated fibrous cap was very short (less than 15 mm). In
the case of these short specimens, Dermabond Advanced (Ethicon Inc.,
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Somerville, NJ, USA) (a topical skin adhesive) was added to the grips in order to
further reduce the potential for specimen slippage within the grips.
Two charge-coupled device (CCD) cameras (Grasshopper GRAS-50S5M,
Point Grey Research, Richmond, BC, Canada) were positioned at a 90° offset from
each other, one providing a front view and the other providing a side view of the
tissue. Images were acquired at 1 Hz throughout each experiment. Small dots of
black tissue marking dye were applied to the front face of the tissue in order to
perform marker tracking and to measure the stretch ratio. The experiments were
performed at a loading and unloading rate of 0.05 mm/s, with additional Belzer UW
solution applied to the tissue at regular intervals (i.e., approximately every two
minutes) during testing to prevent drying.
4.2.2.2 Uniaxial tensile experiments
Uniaxial tensile testing was performed to obtain the stress-strain response
of the tissue. Cyclical displacements of approximately 20% - 30% of the specimen
length were applied, resulting in global strains on the order of 0.20 to 0.30 during
the cyclic strain process. The tissue was preconditioned through multiple loading
and unloading cycles until the maximum load at the end of each cycle reaches
steady state. The loading portion of the last cycle from each experiment was used
to calculate the stress-strain response of the tissue. The stretch ratio was
determined every second using the applied dot pattern. The Cauchy stress is
determined by dividing the instantaneous force by the deformed cross-sectional
area. The cross-sectional area was estimated using specimen width and thickness
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measurements from the images captured by the cameras. The resulting
experimental stress-strain data points were fitted by a second order polynomial
hyperelastic model using Abaqus (Version 6.13-2, Dassault Systèmes Simulia
Corp., Providence, RI, USA) material data fitting tools.
4.2.2.3 Miniature single edge notch tension experiments
As discussed earlier, miniature single edge notch tension (MSENT)
experiments were performed on plaque specimens that were prepared with an
initial crack perpendicular to the direction of the applied load. In these studies, the
initial crack length was between 45% and 70% of the overall width of the tissue.
Cyclical controlled displacement was applied such that the crack extended slowly
during several cycles of loading; each crack extension is approximately 0.4 mm in
length. For the ten specimens where crack extension in the nominally longitudinal
direction occurred from the notch root region, the crack tip opening displacement
(CTOD) is obtained as the crack extends using images acquired during the
MSENT experiments3. CTOD is calculated by measuring the distance between the
intersections of a 90 degree vertex centered at the crack tip with the crack edges,
as first suggested by Rice [92]; a schematic is shown in Figure 4.2. Additionally,
the uniaxial average Cauchy stress in the UCS, σ, is determined at the initiation of
tearing in each cycle as

3

Of the 34 specimens used in our experiments, 13 specimens (38%) failed in the grip
region, 6 (18%) specimens failed in regions away from both the grips and the notch root
and 5 (15%) specimens exhibited tearing across the thickness. Results from these
experiments are not included in this paper.
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𝜎=

𝐹

(4.1)

𝑤∗𝑡

where F is the instantaneous measured load, w is the instantaneous current
remaining width of the UCS and t is the instantaneous current measured thickness
in the UCS.

C

C
L

C
L

R

Figure 4.2 A depiction of the CTOD measurement (left) and the geometry
measurements required for the stress in the UCS calculations (middle and right).
CTOD is calculated by measuring the distance between the intersections of the
sides of a 90 degree vertex centered at the crack tip. The current cross-sectional
area of the UCS is determined by measuring the current width (white line, center
panel) and the current thickness (white line, right panel) of the UCS at the crack
tip. The longitudinal (L), circumferential (C), and radial (R) directions are as shown.
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4.2.3 Histological studies
After mechanical testing, the samples were fixed in a solution of 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, embedded in paraffin, and
sectioned at a thickness of 5 μm. The sections were stained in 0.1% Picrosirius
Red (PSR) in saturated picric acid for 90 minutes, washed for 2 minutes in 0.01 M
hydrochloric acid, dehydrated, cleared, and mounted in Permount. The sections
were analyzed under cross-polarized transmitted light on a Zeiss Axio Imager
microscope. A 10X objective lens was used to collect images from the samples.
Images were captured with a Zeiss AxioCam CCD camera and analyzed for
collagen content using Image-Pro Plus software (Version 5.1.0.20, Media
Cybernetics, Rockville, MD, USA).
Collagen content was determined based on the fractional area of
birefringence observed in the PSR-stained tissue sections. First, an image was
collected in brightfield and the total tissue area was measured using Image-Pro
Plus. Then the same field was examined under cross-polarized light and an image
was collected. The area of the sample that showed green, yellow, or orange-red
birefringence characteristic of collagen was then measured. The collagen content
of the sample as a whole was calculated by comparing the birefringent area to the
total tissue area. This analysis was applied to several regions of each section, as
the sections are sometimes too large to be completely visualized at 10X
magnification. Values of fractional collagen area from the different quadrants were
then averaged to produce a final value for the sample.
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4.2.4 Statistical analysis
Data from multiple samples are reported in terms of the median, first quartile
(IQR1), and third quartile (IQR3) values. Significant relationships between
measured parameters were assessed using linear regression to test the null
hypothesis that the slope is equal to zero. The null hypothesis was rejected, with
statistical significance, if P < 0.05.
4.3 Results
4.3.1 Stress-strain curves
Figure 4.3 presents the stress-strain curves for tensile loading of individual
fibrous cap specimens. As shown in Figure 4.3, there is substantial scatter in
material response that is consistent with previous observations [17-24]. In our
studies, each specimen exhibits non-linear response that is typical of vascular
tissue. Further study of the data shown in Figure 4.3 led the authors to extract
subsets of the overall data that represent (a) the low-strain region and (b) the highstrain region. The low and high strain data sets are separated by manually
identifying the midpoint between the two regions, depicted in Figure 4.4. In
addition, linear regression is performed on the data points in each of these subsets
to identify the tangent modulus. Table 4.2 presents both the tangent moduli and
the stretch ratio at which the shift between the two regions occurs. Results show
that the median [IQR 1, IQR 3] low-strain tangent modulus is 63.1 [29.5, 87.0] kPa,
the median [IQR 1, IQR 3] high-strain tangent modulus is 1006.6 [288.1 1805.1]
kPa, and the median [IQR 1, IQR 3] stretch ratio at the shift between the two data
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sets is 1.13 [1.09, 1.15]. More detailed investigation of the data in Figure 4.3
suggests that there are three major sub-groups in the stress-strain response; a stiff
group (III, V), an intermediate group (II, VI, VII, VIII), and a compliant group (I, IV).
200
180
160

IX

Cauchy Stress (kPa)

140

VII

X
V

120
100
III

80

II

VIII

60
40

IV

20
0
1.00

I

VI
1.05

1.10

1.15

1.20

1.25

1.30

1.35

Stretch Ratio
Figure 4.3 The stress-strain response of several fibrous caps. The dots represent
experimental data points The solid curves represent predictions based on material
model data fitting performed in Abaqus.
Table 4.2 Parameters describing the stress-strain response for each sample
Sample
ID

Low-Strain Tangent
Modulus (kPa)

High-Strain Tangent
Modulus (kPa)

Stretch Ratio
at Shift

I
II
III
IV
V
VI
VII
VIII
IX
X

60.7
16.3
90.9
20.5
75.4
6.64
65.6
149.1
100.7
56.8

142.8
536.8
1972
205.2
2086
44.77
1303
963.0
1050
1995

1.15
1.14
1.05
1.15
1.07
1.09
1.18
1.10
1.16
1.12
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140

Cauchy Stress (kPa)

120
100
80

HighStrain

60
40
20

0
1.00

Low-Strain
Region

Strain at Shift

1.05

1.10

1.15

1.20

Stretch Ratio

Figure 4.4 The low-strain tangent modulus (LSTM), high-strain tangent modulus
(HSTM) and the stretch ratio at shift are determined from the stress-strain curves.
Data from the low-strain region and high-strain region of each stress-strain curve
are fit by linear regression to determine the low-strain tangent modulus and highstrain tangent modulus, respectively. The stretch ratio at shift is determined by
identifying the stretch at the midpoint between the two regions.
4.3.2 Crack tip opening displacement
Figure 4.5 presents the CTOD measurements during crack extension for
the plaque specimens. As shown in Figure 4.5, CTOD increases with increasing
crack extension. This behavior is consistent with ductile materials that exhibit crack
tip blunting. In these studies with relatively small specimens, the overall amount of
crack extension is limited by the geometry of the sample and by the size of the
initial crack. Inspection of the data in Figure 4.5 suggests that CTOD is a linearly
increasing function of crack extension. The median [IQR 1, IQR 3] initial CTOD is
0.54 [0.42, 0.71] mm, and the median [IQR 1, IQR 3] slope of the CTOD
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measurements is 1.30 [0.59, 1.51]. It is important to note that in almost all of the
plaque specimens the initial CTOD values are clustered around 0.5 mm, with the
exception of samples IV, VI and X, which have higher initial CTOD values (0.96
mm, 2.73 mm, and 1.01 mm, respectively).
4.0
X
3.5

VI
IX

CTOD (mm)

3.0

VII

2.5
I
2.0
1.5

II

IV

1.0

V

III

0.5

0
0

0.5

1.0

1.5

2.0

Crack Extension, Δa (mm)

Figure 4.5 The CTOD increases with crack extension (a) for each specimen. The
dashed line shows a trendline through all CTOD data points.
In addition to the CTOD measurements, the radius of curvature of the crack
tip is quantified at the initiation of tearing for each sample as a metric for the degree
of crack tip blunting. Two samples exhibited such a high degree of blunting that a
90 degree vertex did not intersect the edges of the crack. In these cases, CTOD
could not be calculated using the 90o intersection definition (a) for the entire
duration of crack extension in sample VIII and (b) for the final part of crack
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extension in sample VI. Even so, in all cases the radius of curvature of the crack
tip at the initiation of tearing was measured. The median [IQR 1, IQR 3] radius of
curvature of the crack tip at initial tearing is 0.24 [0.13, 0.27] mm.
4.3.3 Stress in the un-cracked segment
Stress in the UCS was calculated at the initiation of tearing for each cycle,
with median [IQR 1, IQR 3] values of 0.366 [0.279, 0.648] MPa. The stress in the
UCS is plotted versus crack extension in Figure 4.6. There appear to be two groups
of responses. One group (I, V, VII) has a high initial stress in the UCS, followed by
much lower stresses at the initiation of additional crack extension. The other group
(II, VI, VIII, IX, X) has relatively constant stresses in the UCS. Samples III and IV
only had one cycle of tearing and therefore only one stress calculation.

Stress in the UCS, σ (MPa)

1.6
1.4
1.2

1.0
IV

0.8
0.6

V

0.4

IX

III

VII

I

VI II

0.2

X

VII
I

0
0

0.5

1.0

1.5

2.0

Crack Extension, Δa (mm)
Figure 4.6 Stress in the UCS versus crack extension for each specimen. Samples
III and IV only had one cycle of tearing and therefore were not evaluated at multiple
crack extensions.
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The initial decrease in stress in the UCS in samples I, V, and VII could arise
from calcification, local variations in collagen content, or varying orientation of
collagen fibers. Additionally, when Figure 4.5 and Figure 4.6 are compared it is
clear that CTOD and stress in the UCS are not directly related. While CTOD is a
strictly increasing function of crack extension, stress in the UCS is essentially
constant, after an initial decrease in some cases.
4.3.4 Collagen content trends
Collagen content was measured in each specimen after mechanical testing
and compared to patient age, initial stress in the UCS, initial CTOD, and initial
radius of curvature at the crack tip (Figure 4.7, Table 4.3). The median [IQR 1, IQR
3] value of fractional collagen content is 32.8 [30.0, 42.0] percent. While there is a
slight decrease in collagen content with age, this is not a significant relationship.
However, there is a statistically significant relationship between collagen content
and the stress in the UCS (P = 0.003 that slope is zero). In addition, there is a
statistically significant inverse trend between the initial CTOD value and total
collagen content (P = 0.019).
The effect of collagen content on CTOD at fixed values of crack extension
was assessed and no significant trends were found (Figure 4.8), suggesting that
other material constituents may be responsible for the slope of the CTOD curve,
or rate of crack tip blunting. The radius of curvature at the crack tip, which is a
measure of the degree of blunting at the crack tip, also is shown to have a
statistically significant inverse relationship with collagen content (P = 0.009). These
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results suggest that samples with higher collagen content begin tearing with a
sharper, narrower crack and exhibit higher stresses at the initiation of tearing.

1.2
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Total Collagen Content (%)
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Figure 4.7 The effect of total collagen content on age, initial stress in the UCS,
initial CTOD and initial radius of curvature of the crack tip. While total collagen
content generally decreases with age, this is not a significant trend (top left). There
is a significant linearly direct relationship between the stress in the UCS and total
collagen content (P < 0.05) (top right). The initial CTOD decreases with increasing
total collagen content and this is a statistically significant relationship (P < 0.05)
(bottom left). There is a statistically significant inverse linear relationship between
the initial radius of curvature of the crack tip and the total collagen content (P <
0.05) (bottom right).
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Table 4.3 Summary of key statistical relationships between selected parameters

Parameter 1

Parameter 2

Relationship

Statistically
Significant

Collagen Content

Age

Inverse Linear

No (P = 0.425)

Collagen Content

Initial CTOD

Inverse Linear

Yes (P = 0.019)

Direct Linear

Yes (P = 0.003)

Inverse Linear

Yes (P = 0.009)

Direct Linear

Yes (P = 0.038)

Collagen Content
Collagen Content
Initial Radius of
Curvature at the
Crack Tip

Initial Stress in
the UCS
Initial Radius of
Curvature at the
Crack Tip
Initial CTOD

4.3.5 Other observations of tissue behavior
During the MSENT experiments, the crack tip exhibited blunting in each
sample. Figure 4.9 shows a representative series of images of the crack both
before and during tissue failure. The radius of curvature of the crack tip is
measured at the initiation of tearing for each cycle. The radius of curvature of the
crack tip increased with each consecutive cycle in every specimen, showing that
the degree of crack tip blunting increases with crack extension. Wells noted that
crack tip blunting increased directly with an increase in toughness of the material
[90]. To examine whether or not our results also show this trend, the initial CTOD
and the initial radius of curvature of the crack tip were compared. We find a
significant direct correlation (P = 0.038), shown in Figure 4.10, that matches Wells’
observations.
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Figure 4.8 Collagen content versus CTOD at selected crack extension values. The
CTOD at selected values of crack extension is determined by linear interpolation
for each specimen. These values are plotted versus collagen content to determine
if collagen content affects CTOD values at other crack extensions. Collagen
content versus initial CTOD (before crack extension) is shown in Figure 4.7. None
of the relationships in this figure are statistically significant.
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Initial Radius of Curvature
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Figure 4.9 Blunting of the crack tip progresses as the tissue tears. The first row
shows the initial, intact specimen (a), the specimen immediately after the notch is
made (b), and the specimen during the deformation before tearing initiated (c-f).
The bottom row shows the progression of blunting as tearing progresses in the
tissue (a-f).
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Figure 4.10 The initial radius of curvature of the crack tip and the initial CTOD
have a significant linearly direct relationship (p < 0.05).
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4.4 Discussion
To the authors’ knowledge, this is the first study that has investigated the
fracture behavior of fibrous cap tissue and the first to use CTOD as a fracture
parameter in vascular tissue. The results show that collagen content plays a
significant role in determining the material’s fracture response, in terms of stresses
observed at fracture, CTOD, and blunting of the crack tip. These results suggest
that collagen fibers are responsible for increasing the load-bearing capacity of
fibrous caps and resisting plastic deformation of the crack tip during fibrous cap
failure.
4.4.1 Validity of results
Obtaining valid fracture toughness measurements in soft biological
materials is inherently difficult, primarily due to limitations of specimen size. The
results in this study show that CTOD increases with crack length, due to an
increase in blunting of the crack tip with each increment of crack extension. There
is no observable significant change in CTOD when the initial crack length is varied.
While the size limitations of fibrous cap specimens make it difficult, if not
impossible, to obtain adequate samples for ASTM standardized testing for fracture
toughness experiments, these results can still be used to add to the understanding
of fibrous cap failure. Atherosclerotic fibrous caps are notoriously heterogeneous
tissues [93]. For this reason, a metric that can provide insight into the relative
mechanical strength of fibrous caps is beneficial. The fracture parameters
quantified in this study can be used to compare resistance to failure between
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samples from different patients and to infer which fibrous caps are more likely to
rupture under specific loading conditions.
4.4.2 Effect of collagen content
The fibrous cap is composed of smooth muscle cells, macrophages, and an
extracellular matrix made up primarily of collagen and proteoglycans [20]. Collagen
type I and collagen type III are the primary structural components [94] in fibrous
caps and are responsible for much of the mechanical response of the tissue. The
results from this study show that collagen content plays a significant role in the
blunting of the crack tip at crack initiation and in the magnitude of stress in the UCS
that is required to initiate tearing. These results predict that a fibrous cap with
higher collagen content will fail at a higher stress with a sharper crack and a lower
initial CTOD. Previous studies have shown that increased collagen content in
fibrous caps leads to a greater stress at tearing and decreased extensibility of the
tissue [95], [96]; these trends are consistent with our observations.
Fibrous caps can be viewed as a fiber-reinforced material with collagen
fibers embedded in the surrounding extracellular matrix. Since collagen is the
primary load bearing protein in the ECM of the fibrous cap, and the remaining
matrix is much weaker than the collagen fibers, the non-collagenous matrix will be
more compliant in achieving plastic deformation and blunting of the crack tip. In
this context, an abundance of collagen fibers will require either breakage of the
collagen fibers or debonding between the fibers and the matrix for the crack tip to
blunt. Thus, the orientation of collagen fibers becomes critical. If collagen fibers
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are aligned parallel to the direction of loading (circumferential orientation), as seen
in the arterial media, then the fibers will increase tensile strength and resist crack
tip blunting prior to the initiation of tearing. However, if collagen fibers are oriented
perpendicular to the loading direction (longitudinal orientation), they will have very
little impact on the material response. In this case, the mechanical response will
be controlled by the interactions between the fibers and the remaining extracellular
matrix, rather than by the fibers themselves. The collagen fiber organization has
not been examined in this study and is relevant future work. Generally, collagen
organization is assumed to be isotropic in the fibrous cap. However, if this is not
the case, the organization of the collagen fibers will play a critical role in
characterizing the material response of fibrous cap tissue.
While collagen content significantly affects the initial CTOD and the initial
stress in the UCS, the importance of collagen content may diminish with crack
extension. Figure 4.8 shows that collagen content has no effect on CTOD beyond
the initial crack extension. Figure 4.6 demonstrates that the range in magnitude of
stress in the UCS is reduced with additional crack extension. Collagen content may
be a good predictor of the initial failure conditions only. After the initial increment
of crack growth, other unidentified material constituents may be responsible for the
fracture behavior.
This study was a portion of a larger study on mechanical properties of
atherosclerotic plaque tissue. Mechanical test data and histological results from
additional fibrous cap and isolated media specimens is shown in Appendix A.
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4.4.3 Notch sensitivity
The effect of the presence of a notch on the mechanical strength of a
material oftentimes is measured by the notch sensitivity ratio (NSR). NSR is the
ratio of the notch strength, or stress required to tear the material when a notch is
present, to the ultimate tensile strength (UTS), which is the stress at which failure
initiates in an un-cracked material. A NSR of 1 is indicative of a material that is not
weakened by the presence of a notch and is known as a notch-insensitive material
[97], [98]. Ideally, the tensile strength would be measured in an un-cracked
specimen and in a cracked specimen with the same material properties, and the
results would be compared pairwise. This approach is logistically difficult in fibrous
cap tissue due to the small size of the specimens and heterogeneity of material
properties. Even samples from the same patient can have noticeably different
results (for example: samples III and IV, samples VII and VIII in this study).
Since our current study has not obtained ultimate tensile strength data for
the small plaque specimens, previous results from the literature may provide some
insight. A few studies measured the UTS of whole plaque specimens [46]–[48] and
at least one study measured UTS in isolated fibrous cap tissue [54]. Teng et al.
report a median [IQR 1, IQR 3] UTS of 0.158 [0.0721, 0.259] MPa in fibrous caps
from symptomatic patients [54], which is much lower than the stress
measurements presented in this study of 0.366 [0.279, 0.648] MPa in fibrous caps
from asymptomatic patients. These results suggest a NSR of approximately 2.3,
which is indicative of a notch-strengthening material. It should be noted that an
apparent NSR greater than one in this case may reflect a difference in material
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properties between plaques from symptomatic versus asymptomatic patients,
rather than the effect of the notch. Future work should include measuring the UTS
of fibrous caps from asymptomatic patients. Additionally, the frequent observation
of failure away from the crack tip supports the idea of a relatively high NSR (≥ 1).
In such cases, tissues with a higher NSR do not have a significant stress
concentration at the crack tip. Therefore, the material is not predisposed to fail
preferentially at the notch tip. It is further noted that notch insensitivity or defect
tolerance is expected to occur in highly fibrous tissues with a relatively uniform
fiber orientation when loaded parallel to the predominant fiber direction. If the
bonding between fibers is relatively poor, then the stress cannot be transmitted
between fibers and the tissue essentially acts as a series of independent fibers
[99].
Clinically, notch insensitivity could be a very beneficial material behavior for
fibrous caps. If a flaw does not create a stress concentration in the fibrous cap, this
gives the tissue an opportunity to heal over time, as long as the critical fracture
criterion is not exceeded during the healing process. For example, if high blood
pressure is experienced for a short time and a small tear occurs in the fibrous cap,
the event may remain clinically silent since the tear will not readily propagate. If
the blood pressure is then lowered, the fibrous cap could repair this tear over time
without an increased risk for future plaque rupture events. However, if high blood
pressure is uncontrolled and maintained long term, the critical failure criterion of
the tissue may be exceeded and the tissue could continue to tear, resulting in a
clinical event such as a stroke or TIA. It is important to note that this analysis does
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not consider the effects of material fatigue, which may also play a significant role
in plaque rupture.
4.4.4 Fracture parameters for fibrous caps
Materials that fracture at a higher stress are considered to be stronger than
materials that fracture at a lower stress. A material with a higher CTOD is
considered more resistant to fracture than a material with a lower CTOD. The
results from this study show that tissues with greater collagen content fail at a
higher stress and a smaller CTOD than those with a lower collagen content. These
divergent fracture parameters suggest a conflicting ranking for the fracture
resistance of fibrous caps. Generally, fibrous cap stability has been assessed by
the stress at which failure occurs, rather than the CTOD or the strain, but our
results and the following discussion suggest that stress may not always be the
most appropriate metric to use. Plaque rupture will occur when the fibrous cap
tissue cannot withstand the loading conditions imposed upon it. While collagenrich fibrous caps are able to withstand higher forces, they are less extensible.
Deformation of an artery, particularly the carotid artery from which these samples
are obtained, is important in vascular health. If the fibrous cap is significantly stiffer
than the underlying media and unable to deform to the same extent, the
discrepancy in material properties may lead to plaque dissection at the shoulders,
a prominent event during balloon angioplasty [24]–[26]. This effect has also been
demonstrated in a finite element model where the plaque tissue is approximately
one order of magnitude stiffer than the medial layer [100]. A mismatch in material
properties between the media and the intima may contribute to the high frequency
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of plaque ruptures at the plaque shoulders. Conversely, fibrous caps with lower
collagen content may deform more readily with the underlying media but may fail
at lower stress values.
Ultimately, the optimal fracture parameter for assessing plaque vulnerability
will depend on the material properties of the fibrous cap, rather than the conditions
to which it is subjected. Our results do not show which fracture parameter will be
best suited for certain situations, such as high stress (high blood pressure) or high
strain (balloon angioplasty, for instance). Instead, our results indicate that fibrous
caps with higher collagen content are stiffer and will likely reach the critical CTOD
before reaching the critical stress, suggesting that CTOD is the appropriate
fracture parameter. Conversely, fibrous caps with lower collagen content will fail at
a lower stress and therefore stress may be the relevant fracture parameter. For
fibrous caps with an intermediate, or unknown, collagen content, it may be
necessary to evaluate both fracture parameters.
Knowledge of the collagen content in the fibrous cap can give insight into
the failure behavior of the material. Time-resolved laser induced fluorescence
spectroscopy, a catheter-based imaging technique, has been shown to detect
collagen content in atherosclerotic plaques [101]. This technique may be useful in
determining collagen content, and thereby estimating material behavior of the
fibrous cap, prior to clinical intervention. In particular, an estimation of the plaque
mechanical properties could help assess the optimal treatment for carotid artery
stenosis. Carotid endarterectomy (CEA) is generally considered the standard
treatment for carotid artery stenosis, but recently carotid artery stenting (CAS) has
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been suggested as an alternative, less invasive, technique. CAS has been shown
to result in more strokes during the periprocedural period than CEA [27]–[29],
which may be a result of the high strain applied on fibrous caps with high collagen
content during balloon angioplasty. This increased risk of stroke during the
periprocedural period may be reduced if the material properties of the plaque are
considered prior to selecting a treatment. While CAS may be a suitable alternative
to CEA in some cases, CAS may not be the optimal treatment for patients with
high collagen content in the fibrous cap.
4.5 Conclusions
This study shows, for the first time, that CTOD can be used as a
comparative metric for fracture toughness in atherosclerotic fibrous cap samples
from individual patients. Collagen content is important in determining the
mechanical behavior and response of fibrous caps in atherosclerosis. A fibrous
cap with higher collagen content fails at a higher stress and lower CTOD than
fibrous caps with lower collagen content. Furthermore, high collagen content is
associated with a sharper crack tip, suggesting that collagen fiber-rich tissue
impedes blunting of the crack tip. Additionally, the results suggest that fibrous caps
may exhibit notch insensitivity or even notch strengthening behavior. Lastly, these
results show that analyzing the stress in fibrous caps provides only one part of the
picture when considering the problem of plaque rupture. The strain, or deformation,
which a fibrous cap is able to withstand is also an important aspect of plaque
stability which is often ignored in the analysis of plaque rupture.
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CHAPTER 5
CONCLUSIONS
5.1 Dissertation Summary
The overall aim of this project was to use fracture mechanics concepts to
characterize atherosclerotic plaque failure. To achieve this goal, fracture
toughness was measured in both mouse and human plaques to assess adhesion
strength and during tearing failure of human fibrous caps from carotid
endarterectomy specimens. In addition, failure behavior of thin protein films was
studied in vitro to measure the adhesion strength of selected proteins,
The adhesion strength between atherosclerotic plaques and IEL as well as
the failure load are unchanged between ApoE-/- and ApoE-/- Col8-/- mice. However,
the plaques in ApoE-/- Col8-/- mice are less stiff than those in ApoE-/- mice. While
human atherosclerotic plaques are much stronger than those found in mice, the
plaque adhesion strength data sets are qualitatively similar, in terms of having
positively skewed distributions of energy release rate and standard deviations
which are approximately equal to the means.
Investigating the plaque-IEL interface further, this study shows that
contributions of adhesive matrix proteins to the strength of the plaque-IEL interface
can be measured with a novel technique. Semi-quantitative plaque immunoblotting
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combined with RDCB experiments shows that collagen IV alone is not likely to be
responsible for the adhesive strength of the plaque-IEL interface. SEM images of
a partially delaminated plaque show bridging fibers that connect the plaque and
the IEL. The adhesive strength of the plaque-IEL interface likely derives from
tensile strength of these bridging fibers, potentially composed of collagen I, fibrillin1, or other structural matrix proteins, rather than from protein adhesion/cohesion.
To characterize plaque susceptibility to tensile rupture of the fibrous cap,
this study investigated the fracture toughness of human fibrous caps. The results
show, for the first time, that CTOD can be used as a comparative metric for fracture
toughness in atherosclerotic fibrous cap samples from individual patients.
Collagen content is important in determining the mechanical behavior and
response of fibrous caps in atherosclerosis. A fibrous cap with higher collagen
content exhibits more brittle behavior and fails at a higher initial stress and lower
initial CTOD than fibrous caps with lower collagen content. Collagen fibers act to
impede blunting of the crack tip and increase tensile strength of the tissue.
Knowledge of the collagen content in the fibrous cap prior to surgical intervention
could predict the mechanical response of the fibrous cap and aid in determining
the optimal treatment plan.
Fracture toughness was used to assess plaque resistance to two different
failure mechanisms: 1) plaque delamination at the plaque-IEL interface and 2)
tensile rupture of the fibrous cap. Collagen is a vital structural component of
atherosclerotic plaques and is crucial in determining the mechanical response of
fibrous caps. Fibrillar forms of collagen, such as collagen I, or other fibrillar
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proteins, such as fibrillin-1, are likely responsible for the mechanical strength of the
plaque-IEL interface.
5.2 Future Studies
There are several questions that arise from the results of the current study.
The results from Chapter 3 show that collagen IV is too weak to account for the
mechanical strength of the plaque-IEL interface in mice, measured in situ in
Chapter 2. However, these results do not rule out all adhesive proteins as
contributors to the mechanical strength at the plaque-IEL interface and therefore
the mechanical strength of other adhesive proteins should be investigated.
Additionally, the technique we used does not distinguish between adhesive
strength between the protein and the underlying matrix and cohesive strength
within the protein layer. If adhesive proteins are responsible in part for the
mechanical strength of the plaque-IEL interface, distinguishing between cohesive
strength and adhesive strength will be important in understanding the detailed
failure mechanism.
While all adhesive proteins have not been excluded as potential contributors
to plaque-IEL bonding, the role of bridging fibers at the plaque-IEL interface should
also be investigated. Specifically, the number, diameter, and composition of these
bridging fibers should be further investigated with immunogold SEM. Additionally,
the mechanical strength of these bridging fibers should be investigated and
compared to the in situ measurements from Chapter 2.
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The results from Chapter 4 describe an interesting characterization of
fibrous cap mechanical properties. The initial failure criteria can be predicted by
collagen content; however, this trend no longer exists with additional crack
extension. This change may be due to a movement or realignment of the collagen
fibers ahead of the crack tip as the crack extends. Fiber realignment could be
investigated using second-harmonic generation (SHG) microscopy to view
collagen fiber organization after a small increment of crack growth.
If collagen fibers are in fact realigning during crack extension, the effect of
displacement rate on the experimental results should also be investigated. The
strain rate in vivo is much higher than the displacement rate of the experiments,
and the slower experimental displacement rate may allow the tissue a chance to
respond to crack extension, potentially by fiber realignment, which does not exist
in vivo.
The degree of fiber realignment may be constrained by the relative stiffness
of the surrounding non-collagenous matrix. For this reason, other constituents of
the fibrous cap, such as macrophages, SMCs, and proteoglycans, should be
investigated.
The ECM constituents quantified in plaque tissue should be related to the
mechanical response of these tissues obtained from uniaxial tensile tests
performed on the same specimens (see Appendix A). Specifically, the HolzapfelGasser-Ogden (HGO) model parameters should be determined for each sample
using computational simulations. A structure based constitutive model for each
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tissue type can be created by combining the HGO parameters with the material
constituents in each sample. These results will be particularly useful to the
computational modeling community as there is limited data available in the
literature regarding material properties of atherosclerotic plaque for use in
simulations.
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APPENDIX A
ADDITIONAL MECHANICAL TEST DATA AND HISTOLOGICAL
RESULTS FROM HUMAN ATEROSCLEROTIC PLAQUES
Chapter 4, a study on the fracture resistance of atherosclerotic fibrous caps,
was a portion of a larger study on mechanical properties of atherosclerotic plaque
tissue. This appendix presents additional mechanical test data and histological
studies performed on human atherosclerotic plaque tissue.
Mechanical testing was performed on strips of isolated fibrous cap (FC),
media underlying atherosclerotic lesions (diseased media, DM), and media from
relatively healthy sections of tissue (normal media, NM). Stress-strain curves
obtained from uniaxial tensile experiments performed on strips of atherosclerotic
plaque tissue (see section 4.2.2.2 for full experimental methodology) are presented
in Figure A.1.
There is a lot of scatter both within and between tissue types, similar to
section 4.3.1. However, the average diseased media specimen is somewhat stiffer
than the average normal media specimen. The mechanical response of the fibrous
cap specimens is similar to that of the media specimens. After mechanical testing,
each specimen was fixed in 4% paraformaldehyde in phosphate buffer and stored
at 4 °C.
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Figure A.1 Stress-strain relationships for strips of isolated normal media, diseased
media, and fibrous cap from human carotid endarterectomy specimens.
Collagen content and elastin content were determined in each fixed sample
saved following mechanical testing using standard histological techniques.
Collagen content was determined in each sample by staining with Picrosirius Red
(PSR) and following the protocol in section 4.2.3. Additionally, elastin content was
determined by staining with Verhoeff solution and calculating the area of black
tissue (elastin) relative to the total tissue area. Representative images of trichrome
staining, PSR staining, and Verhoeff staining are shown in Figure A.2 for each
tissue type. The histology performed on normal media (top row) shows some
intimal thickening is present in this tissue, most clearly visible in the Verhoeff stain
(right column). This is not surprising as this tissue is immediately adjacent to
advanced atherosclerotic lesions and therefore is likely to exhibit some
characteristics of the diseased state.
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Figure A.2 Representative trichrome (left column), Picrosirius Red (middle column)
and modified Verhoeff (right column) staining for normal media (top row), diseased
media (middle row) and fibrous cap (bottom row). Scale bars represent 100 μm.
The results from quantification of the histological images from 5 specimens
per tissue type are shown in Figure A.3 and Table A.2. One way ANOVA confirms
that there are significant differences in both collagen and elastin content between
tissue types. Tukey’s Honestly Significant Different test confirms that collagen
content in the fibrous cap is significantly different from both normal and diseased
media. The elastin content in the fibrous cap is significant different from that the in
normal media, but not the diseased media. There are no significant differences in
collagen or elastin content between normal and diseased media.
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Figure A.3 Collagen and elastin content in normal media (NM), diseased media
(DM), and fibrous cap (FC). Error bars represent standard deviation.
Table A.1 Summary of histological results for each tissue type
Tissue

Sample ID

Collagen %

Elastin %

Normal Media

NM1
NM2
NM3
NM4
NM5
Average

22.1
36.0
12.0
12.1
18.4
20.1 ± 9.8

7.0
11.5
17.7
30.6
16.5
16.7 ± 8.9

Diseased Media

DM1
DM2
DM3
DM4
DM5
Average

32.5
26.3
6.3
18.4
7.7
18.3 ± 11.4

5.8
6.0
25.1
5.7
17.3
12.0 ± 8.9

Fibrous Cap

FC1
FC2
FC3
FC4
FC5
Average

30.4
37.6
38.5
39.8
43.4
37.9 ± 4.8

0.72
0.57
1.3
1.1
1.9
1.1 ± 0.5
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